<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 /home/lopez/grobid/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">3’-Deoxyadenosine (Cordycepin) Produces a Rapid and Robust Antidepressant Effect via Enhancing Prefrontal AMPA Receptor Signaling Pathway</title>
			</titleStmt>
			<publicationStmt>
				<publisher>Oxford University Press (OUP)</publisher>
				<availability status="unknown"><p>Copyright Oxford University Press (OUP)</p>
				</availability>
				<date type="published" when="2015-10-06">October 6, 2015</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><roleName>MSc</roleName><forename type="first">Bai</forename><surname>Li</surname></persName>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><roleName>BSc</roleName><forename type="first">Yangyang</forename><surname>Hou</surname></persName>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><roleName>PhD</roleName><forename type="first">Ming</forename><surname>Zhu</surname></persName>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><roleName>MSc</roleName><forename type="first">Hongkun</forename><surname>Bao</surname></persName>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><roleName>BSc</roleName><forename type="first">Jun</forename><surname>Nie</surname></persName>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><roleName>BSc</roleName><forename type="first">Grace</forename><forename type="middle">Y</forename><surname>Zhang</surname></persName>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><roleName>MSc</roleName><forename type="first">Liping</forename><surname>Shan</surname></persName>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><roleName>BSc</roleName><forename type="first">Yao</forename><surname>Yao</surname></persName>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><roleName>MSc</roleName><forename type="first">Kai</forename><surname>Du</surname></persName>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><roleName>PhD</roleName><forename type="first">Hongju</forename><surname>Yang</surname></persName>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><roleName>PhD</roleName><forename type="first">Meizhang</forename><surname>Li</surname></persName>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><roleName>PhD</roleName><forename type="first">Bingrong</forename><surname>Zheng</surname></persName>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><roleName>MD</roleName><forename type="first">Xiufeng</forename><surname>Xu</surname></persName>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><roleName>PhD</roleName><forename type="first">Chunjie</forename><surname>Xiao</surname></persName>
						</author>
						<author role="corresp">
							<persName xmlns="http://www.tei-c.org/ns/1.0"><roleName>MD</roleName><forename type="first">Jing</forename><surname>Du</surname></persName>
							<email>dujing@ynu.edu.cn</email>
						</author>
						<author>
							<affiliation key="aff0">
								<orgName type="department">School of Medicine</orgName>
								<orgName type="institution">Yunnan University</orgName>
								<address>
									<settlement>Kunming</settlement>
									<region>Yunnan</region>
									<country key="CN">China</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff1">
								<orgName type="department" key="dep1">Institute of Genetics and Developmental Biology, Chinese Academy of Sciences</orgName>
								<orgName type="department" key="dep2">Department of Biochemistry &amp; Molecular Biology</orgName>
								<orgName type="department" key="dep3">School of Life Sciences</orgName>
								<orgName type="department" key="dep4">Department of Psychiatry</orgName>
								<orgName type="department" key="dep5">The First Affiliated Hospital of Kunming Medical University</orgName>
								<orgName type="laboratory">Xiao, and J Du); Beijing Gragen Biotechnology Co. Ltd</orgName>
								<orgName type="institution">Yunnan University</orgName>
								<address>
									<addrLine>China (Ms Zhang, China (Mr K Du), Yunnan, China (Dr M Li)</addrLine>
									<settlement>Beijing, Shan, Beijing, Kunming, Kunming</settlement>
									<region>Yunnan</region>
									<country key="CN">China</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff2">
								<orgName type="department">School of Medicine</orgName>
								<orgName type="institution">Yunnan University</orgName>
								<address>
									<addrLine>2 Cuihu North Road</addrLine>
									<postCode>650091</postCode>
									<settlement>Kunming</settlement>
									<region>Yunnan, P. R. China</region>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">3’-Deoxyadenosine (Cordycepin) Produces a Rapid and Robust Antidepressant Effect via Enhancing Prefrontal AMPA Receptor Signaling Pathway</title>
					</analytic>
					<monogr>
						<title level="j" type="main">International Journal of Neuropsychopharmacology</title>
						<title level="j" type="abbrev">IJNPPY</title>
						<idno type="ISSN">1461-1457</idno>
						<idno type="eISSN">1469-5111</idno>
						<imprint>
							<publisher>Oxford University Press (OUP)</publisher>
							<biblScope unit="volume">19</biblScope>
							<biblScope unit="issue">4</biblScope>
							<biblScope unit="page">pyv112</biblScope>
							<date type="published" when="2015-10-06">October 6, 2015</date>
						</imprint>
					</monogr>
					<idno type="DOI">10.1093/ijnp/pyv112</idno>
					<idno type="PMID">26443809</idno>
					<idno type="PMCID">PMC4851261</idno>
					<ptr type="open-access" target="https://academic.oup.com/ijnp/article-pdf/19/4/pyv112/9523183/pyv112.pdf" />
					<note type="submission">Received: May 29, 2015; Revised: September 7, 2015; Accepted: September 29, 2015</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.6.2-SNAPSHOT" ident="GROBID" when="2020-08-13T22:37+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>3&apos;-deoxyadenosine</term>
					<term>synapse</term>
					<term>animal behavior</term>
					<term>GluR1</term>
					<term>rapid antidepressant</term>
				</keywords>
			</textClass>
			<abstract>
				<p>Background: The development of rapid and safe antidepressants for the treatment of major depression is in urgent demand. Converging evidence suggests that glutamatergic signaling seems to play important roles in the pathophysiology of depression. Methods: We studied the antidepressant effects of 3 &apos;-deoxyadenosine (3&apos;-dA, Cordycepin) and the critical role of the α-amino-3hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptor in male CD-1 mice via behavioral and biochemical experiments. After 3&apos;-dA treatment, the phosphorylation and synaptic localization of the AMPA receptors GluR1 and GluR2 were determined in the prefrontal cortex (PFC) and hippocampus (HIP). The traditional antidepressant imipramine was applied as a positive control. Results: We found that an injection of 3&apos;-dA led to a rapid and robust antidepressant effect, which was significantly faster and stronger than imipramine, after 45 min in tail suspension and forced swim tests. This antidepressant effect remained after 5 days of treatment with 3&apos;-dA. Unlike the psycho-stimulants, 3&apos;-dA did not show a hyperactive effect in the open field test. After 45 min or 5 days of treatment, 3&apos;-dA enhanced GluR1 S845 phosphorylation in both the PFC and HIP. In addition, after 45 min of treatment, 3&apos;-dA significantly up-regulated GluR1 S845 phosphorylation and GluR1, but not GluR2 levels, at the synapses in the PFC. After 5 days of treatment, 3&apos;-dA significantly enhanced GluR1 S845 phosphorylation and GluR1, but not GluR2, at the synapses in the PFC and HIP. Moreover, the AMPA-specific antagonist GYKI 52466 was able to block the rapid antidepressant effects of 3&apos;-dA.</p>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p>Due to the millions of individuals who suffer from major depression today, and the delayed efficacy of the existing therapeutic agents, there exists an interest in finding a safer compound with robust and rapid antidepressant effects <ref type="bibr" target="#b34">(Krystal et al., 2013;</ref><ref type="bibr" target="#b9">Caddy et al., 2014)</ref>. The most famous rapid antidepressant, Ketamine, a non-competitive N-methyl-D-aspartate (NMDA) receptor antagonist, was found to rely on increasing α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) signaling to exert its antidepressant efficacy <ref type="bibr" target="#b41">(Maeng et al., 2008)</ref>. A previous study has shown that a traditional Chinese medicine, Cordyceps Militaris powder, demonstrated an antidepressant effect in the tail suspension test <ref type="bibr">(TST;</ref><ref type="bibr" target="#b50">Nishizawa et al., 2007)</ref>. Moreover, 3'-deoxyadenosine (3'-dA, Cordycepin), one of the major bioactive metabolites in the Cordyceps Militaris <ref type="bibr" target="#b68">(Tuli et al., 2013)</ref>, exerted a beneficial effect in a 6-week chronic unpredictable mild stress (CUMS) mouse model via the forced swim test (FST; <ref type="bibr" target="#b66">Tianzhu et al., 2014)</ref>. 3'-dA possesses a wide range of beneficial effects of therapeutic potential, including anti-insomnia, antiinflammatory, anti-cancer, anti-viral, and anti-fungal activities <ref type="bibr" target="#b27">(Hu et al., 2013;</ref><ref type="bibr" target="#b68">Tuli et al., 2013)</ref>. However, whether or not 3'-dA has a fast-acting antidepressant effect remains unknown.</p><p>Glutamate mediates the vast majority of excitatory transmissions and about 80% of neurons form 85% of the synapses, which are spiny and excitatory in the central nervous system (CNS; <ref type="bibr" target="#b16">Douglas and Martin, 2007;</ref><ref type="bibr" target="#b61">Sanacora et al., 2012)</ref>. A growing body of evidence suggests that the glutamatergic system might be very important in the pathophysiology and treatment of depression <ref type="bibr" target="#b33">(Krystal et al., 2002;</ref><ref type="bibr" target="#b61">Sanacora et al., 2012;</ref><ref type="bibr" target="#b46">Musazzi et al., 2013;</ref><ref type="bibr" target="#b54">Pilc et al., 2013)</ref>. The AMPA receptor channel is a tetramer assembled from the four subunits, including GluR1, GluR2, GluR3, and GluR4. Clinical evidence has shown that the expression of AMPA receptors, particularly GluR1, is decreased in the brains of patients with depression <ref type="bibr" target="#b4">(Beneyto et al., 2007;</ref><ref type="bibr" target="#b22">Duric et al., 2013)</ref>. Additionally, the trafficking of AMPA receptor subunit GluR1 and synaptic plasticity are regulated by the phosphorylation of specific subunits <ref type="bibr" target="#b44">(Malinow and Malenka, 2002;</ref><ref type="bibr" target="#b23">Esteban et al., 2003)</ref>. Phosphorylation of GluR1 at serine 845 (S845) was increased following antidepressant treatment with flouxetine or tianeptine in mice <ref type="bibr" target="#b64">(Svenningsson et al., 2002</ref><ref type="bibr" target="#b65">(Svenningsson et al., , 2007</ref>, suggesting that phosphorylation of GluR1 might be associated with the potentiation of AMPA receptor currents <ref type="bibr" target="#b70">(Wang et al., 2005)</ref>. Previous studies have shown that phosphorylation of GluR1 at S845 and GluR1 synaptic localization might be common mechanisms for the agents with antidepressant efficacy, such as imipramine, lamotrigine, and riluzol <ref type="bibr" target="#b19">(Du et al., 2007;</ref><ref type="bibr" target="#b25">Gould et al., 2008)</ref>. However, whether 3'-dA regulates AMPA synaptic plasticity is still unknown.</p><p>Based on these premises, we designed a series of behavioral and biochemical experiments to investigate the antidepressant effects of 3'-dA in animal models of depression. We studied the rapid and chronic effects of various concentrations of 3'-dA via behavioral tests, including the TST, FST, and open field test (OFT). The phosphorylation of GluR1 S845 and synaptic localization of GluR1 and GluR2 were determined in the prefrontal cortex (PFC) and hippocampus (HIP) after 45-min and 5-day treatments. In addition, the role of the enhanced AMPA function in the rapid antidepressant effect was addressed by pretreatment with AMPA receptor-specific antagonist GYKI 52466 followed by TST.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Materials and Methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Animal Behavioral Studies</head><p>All animal treatments, procedures, and care were approved by the medical ethics committee of the School of Medicine, Yunnan University, and followed the Guide for the Care and Use of Laboratory Animals (ISBN 0-309-05377-3). Male CD-1 mice (6 weeks; starting weight, 23-28 g; Vital River) were group housed (n = 4/cage) in an animal room with a constant temperature (21 ± 3°C) and maintained on a 12-hour light/dark cycle (lights on/off at 09:00 and 21:00 hours), with constant humidity (55 ± 10%) and free access to water and food. After a 1-week acclimatization period, the mice were treated with drugs or vehicle in a volume of 10 μl/g by intraperitonial (i.p.) injection and tested between 10:00 and 14:00 hours.</p><p>To examine the rapid (45-min treatment) and chronic (5-day treatment) antidepressant effects of 3'-dA (Sigma), mice were randomly assigned to four treatment groups: saline (0.9% sterile sodium chloride solution), low dose of 3'-dA (5 mg/kg, dissolved in saline), high dose of 3'-dA (12.5 mg/kg, in saline), and imipramine (15 mg/kg, in saline; Sigma). Animal behavioral tests were performed 45 minutes after drug or vehicle administration, TST was performed on the first day, OFT on the third day, and FST on the fifth day. To confirm the rapid and chronic antidepressant effects of 3'-dA, another two batches of mice were subjected to the FST and TST, respectively, under similar settings.</p><p>To examine whether the rapid antidepressant effect of 3'-dA could be blocked by GYKI 52466 (a selective non-competitive AMPA receptor antagonist; TOCRIS Bioscience, R&amp;D), mice were treated with GYKI 52466 (30 mg/kg in 26% DMSO/74% saline), followed by a high dose of 3'-dA treatment. Since a previous study showed that plasma levels of GYKI 52466 peaked at 15 minutes after i.p. injection and then fell to 21% of the peak value at 60 minutes <ref type="bibr" target="#b14">(De Sarro et al., 1998)</ref>, we administered GYKI 15 minutes before 3'-dA treatment and performed the TST 45 minutes later. For each drug treatment, the control mice received the respective vehicle alone.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Tail Suspension Test</head><p>A 7 cm long and 2 cm wide tape was positioned with approximately 2 mm of tail protruding. In a series of pilot experiments using this procedure, we observed that no mice climbed their tails. Each mouse was individually suspended by the tail from a bar (30 cm high) and videotaped during a 6-min test session. Immobility time was quantified by a naive observer for the last 4 minutes.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Open Field Test</head><p>An activity chamber (60 × 60 × 30 cm) with a black floor divided into 16 squares of an equal area (15 × 15 cm) by white lines was used to study 3'-dA-induced hyperactivity. After 3 days of i.p. injection of drugs, mice were placed in the center of the chamber and their behavior was recorded for 60 minutes. Total distance traveled and the amount of distance traveled in the center area (the 4-square area in the middle of the chamber) were analyzed by Anymaze system (Stoelting).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Forced Swim Test</head><p>Mice were placed in a cylinder (Ф = 20 cm) with water 20 cm in depth (temperature between 23 ± 1°C). Mice were videotaped during a 6-min test session, which was later analyzed by a naive observer for activity during the final 4 minutes. Mobility was defined as any movement beyond what was necessary to maintain the head above water.</p><p>After the behavioral experiments, all mice were decapitated immediately. The PFC and HIP were dissected, frozen rapidly in liquid nitrogen, and stored at −80°C until further analysis.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Western Blot Analysis</head><p>PFC or HIP tissue was lysed with an ice-cold radioimmunoprecipitation assay buffer (20 mM Tris [pH 7.5], 150 mM NaCl, 1% Triton X-100, sodium pyrophosphate, β-glycerophosphate, EDTA, Na 3 VO 4, leupeptin plus a Protease Inhibitor Cocktail Tablet <ref type="bibr">[Roche]</ref>, and Phosphatase Inhibitor Cocktail Tablet <ref type="bibr">[Roche]</ref>) in a tissue grinder (Wheaton). Protein concentrations were determined using the BCA protein assay kit <ref type="bibr">(Pierce Biotechnology)</ref>. Equal amounts of proteins were subjected to 7-10% SDS-PAGE gels electrophoresis, then transferred to polyvinylidene difluoride (PVDF) membranes (Pall) and blocked with 1% BSA in TBST (0.1% Tween). Antibodies against Phos-GluR1 S845 (Rabbit mAb, 1:1000, Cell Signaling Technology) and GluR1 (Goat pAb, 1:1000, Santa Cruz) in 5% BSA-TBST were applied to the membranes. The secondary antibodies were horseradish peroxidase conjugated goat anti-rabbit (1:5000, Affinity Bioscience) or donkey anti-goat antibodies (1:5000, Santa Cruz). Antibody for β-actin (Mouse mAb, 0.2 μg/ml, Affinity Bioscience) was applied for loading calibration. Immunoreactive bands were visualized using the ECL detection system (Millipore). Images were acquired by the FlourChem E image system (FE0511, ProteinSimple) and quantified by the Image-Pro Plus Version 6.0 software (Media Cybernetics).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Synaptosomes Preparation</head><p>Synaptosomal fractions were prepared from PFC or HIP tissue using the differential and discontinuous Ficoll gradient centrifugation method <ref type="bibr" target="#b55">(Pozzo-Miller et al., 1999;</ref><ref type="bibr" target="#b17">Du et al., 2004a</ref><ref type="bibr" target="#b20">Du et al., , 2008</ref>. Tissue was homogenized by tissue grinder and then electronic polytron homogenizer (AutoScience) in cold Syn buffer (300 mM mannitol and 1 mM EDTA, pH 7.4). The crude homogenates were centrifuged at 5000 × g for 10 minutes and the supernatants were again centrifuged at 15000 × g for 30 minutes. The resuspended pellets were loaded on Ficoll gradient tubes and centrifuged at 22000 × g for 90 minutes. The 8/12% and 12/16% interfaces were carefully removed, diluted in Syn buffer in a ratio of 1:4, and centrifuged for 20 minutes at 15000 × g. Pellets were resuspended and lysed with Lysis buffer. All samples were constantly maintained at 4°C during all steps. Western blot was applied to analyze the synaptic expressions of Phos-GluR1 S845, GluR1, and GluR2 (Rabbit mAb, 1:2000, Abcam).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statistical Analysis</head><p>All data were analyzed by one-way ANOVA and post hoc Bonferroni (unequal sample) or Tukey (equal sample) tests and presented as the mean ± standard error via SPSS 17. A p-value less than 0.05 was considered a significant difference. Figures were generated by Graphpad Prism Version 5 software.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>3'-dA Demonstrated a Rapid and Significant Antidepressant Effect</head><p>To investigate whether 3'-dA plays a role in regulating depression-like behavior, we i.p. injected the 7-week-old CD-1 mice with a low (5 mg/kg) or high (12.5 mg/kg) dose of 3'-dA for 45 minutes or 5 days. 45 minutes after the treatment, mice were subjected to either the TST or FST. The data showed that the immobility times in the 3'-dA-treated groups were significantly lower than in the controls (101.74 ± 6.49 sec) in a dose dependent manner: 54.60 ± 7.73 sec (for 12.5 mg/kg of 3'-dA) and 76.57 ± 6.49 sec (for 5 mg/kg of 3'-dA) in the TST ( <ref type="figure">Figure 1A</ref>). It is noteworthy that the high dose of 3'-dA (12.5 mg/kg) reduced the immobility time of TST to a much larger extent than that of the comparable traditional antidepressant imipramine (15 mg/kg; <ref type="figure">Figure 1A</ref>). To confirm the data in the TST, the FST was performed under similar settings. After 45 minutes of treatment with 3'-dA, the high dose group also demonstrated a stronger antidepressant effect, as low as 48.23 ± 10.11 sec, compared with the control (92.69 ± 9.24 sec) and the imipramine group (79.92 ± 9.92 sec; <ref type="figure">Figure 1B</ref>).</p><p>To further study this antidepressant effect for long-term treatment, we treated the mice with a low (5 mg/kg) or high (12.5 mg/kg) dose of 3'-dA for 5 days, then performed the TST and FST. The data showed that both low and high doses of 3'-dA significantly decreased immobility time, to 50.35 % and 55.36 % <ref type="figure">Figure 1</ref>. 3 ' -deoxyadenosine (3'-dA) demonstrated rapid and significant antidepressant effects in the tail suspension test (TST) and forced swim test (FST). CD-1 mice were i.p. injected with a low dose of 3'-dA (5 mg/kg/day, dA-L), a high dose of 3'-dA (12.5 mg/kg/day, dA-H), imipramine (15mg/kg/day, IMI), or saline (Sal). 45 minutes after the drug injection, mice were subjected to the TST or FST. The number of mice per group is indicated in each individual graph. Data were analyzed by one-way ANOVA and presented as mean ± standard error (post hoc Bonferroni test, *p &lt; 0.05, **p &lt; 0.01, ***p &lt; 0.001; post hoc Tukey test, ★p &lt; 0.05, ★★p &lt; 0.01). (A, B) 45 minutes after the injection, 3'-dA significantly reduced the immobility time in the TST and FST. (C, D) After 5 consecutive days of injection, 3'-dA significantly reduced the immobility time in the TST and FST.</p><p>of control in the TST and 64.95 % and 36.78 % of control in the FST, respectively, in a dose-dependent manner. Imipramine also showed a stable and strong antidepressant effect in both the TST and FST ( <ref type="figure">Figure 1C</ref> and D).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Unlike the Psycho-Stimulants, 3'-dA Did Not Show Locomotor Hyperactivity in the OFT</head><p>To further determine whether 3'-dA causes locomotor hyperactivity, one of the core features of mania-like symptoms, we performed the OFT after 3 days of treatment with a low or high dose of 3'-dA. The total distance traveled showed no significant difference in 3'-dA-treated groups compared with controls, suggesting that 3'-dA does not cause hyperactivity in mice <ref type="figure" target="#fig_0">(Figure 2A</ref>). This is different from the psycho-stimulant amphetamine, which significantly increased the total distance travelled in rats during the OFT <ref type="bibr" target="#b36">(Labonte et al., 2012)</ref>. 3'-dA showed a trend to increase the distance travelled in the center area, but it was not statistically significant ( <ref type="figure" target="#fig_0">Figure 2B</ref>). The weights of mice after 5 days of treatment did not show a significant difference ( <ref type="figure" target="#fig_0">Figure 2C</ref>).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>After 45 Min of Treatment, High Concentration of 3'-dA Enhanced AMPA GluR1 S845 Phosphorylation in the PFC and HIP</head><p>Previous studies from our group showed that phosphorylation of AMPA GluR1 S845 presented a common mechanism for the treatment of depression <ref type="bibr" target="#b19">(Du et al., 2007)</ref>. In this context, we further addressed whether Phos-GluR1 S845 levels were changed after treatment with 3'-dA. We found that after 45 minutes of i.p. injection, the phosphorylation of GluR1 S845 was rapidly and significantly increased in both the PFC and HIP from the high-dose 3'-dA-treated group ( <ref type="figure" target="#fig_1">Figure 3A)</ref>. In contrast, the phosphorylation of GluR1 S845 in the imipramine-treated group remained unchanged after 45 minutes of treatment, which is consistent with the fact that the antidepressant effects of imipramine were not significant after 45 minutes of treatment ( <ref type="figure">Figures 1A and B</ref> and 3A). The levels of total GluR1 proteins in these brain regions remained unchanged ( <ref type="figure" target="#fig_1">Figure 3B</ref>).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>After 5 Days of Treatment, 3'-dA and Imipramine Enhanced AMPA GluR1 S845 Phosphorylation in Both the PFC and HIP</head><p>To determine the long-term effects of 3'-dA, we treated the mice with 3'-dA for 5 days, and found that the phosphorylation of GluR1 S845 was significantly increased in both the low (175.44 ± 14.32%; 169.86 ± 11.83%) and high (174.75 ± 13.00%; 158.06 ± 11.62%) dose groups in the PFC and HIP, respectively ( <ref type="figure" target="#fig_1">Figure 3C</ref>). The imipramine-treated group also demonstrated a significant increase in Phos-GluR1 S845 levels in both the PFC (163.02 ± 12.08%) and HIP (148.52 ± 12.16%) after 5 days of treatment ( <ref type="figure" target="#fig_1">Figure 3C</ref>), which is consistent with a previous publication <ref type="bibr" target="#b19">(Du et al., 2007)</ref>. The total GluR1 levels in the PFC and HIP remained unchanged ( <ref type="figure" target="#fig_1">Figure 3D</ref>).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>After 45 Min of Treatment, 3'-dA Significantly Up-Regulated AMPA GluR1 S845 Phosphorylation and GluR1 Levels at the Synapses in the PFC</head><p>To further determine whether GluR1 localization at the synapses in the PFC or HIP was increased, we isolated the synaptosomal fractions from the PFC and HIP tissue. Western blot analysis of Phos-GluR1 S845, GluR1, and GluR2 were performed with the synaptic fractions. Here, we found that levels of GluR1 and GluR2 were significantly enriched at the synapses, compared with the total protein ( <ref type="figure" target="#fig_2">Figure 4A</ref>). After 45 minutes of treatment with the high dose of 3'-dA (12.5 mg/kg), Phos-GluR1 S845 and GluR1 levels, but not GluR2 levels, were significantly increased in the synaptosomal fractions in the PFC ( <ref type="figure" target="#fig_2">Figures 4B and C and 5A)</ref>. It is noteworthy that the acute treatment of the traditional antidepressant imipramine did not lead to a significant increase in GluR1 levels at the synapses ( <ref type="figure" target="#fig_2">Figure 4C</ref>), which is consistent with the results in the TST and FST after 45 minutes of treatment ( <ref type="figure">Figure 1A and B</ref>).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>After 5 Days of Treatment, 3'-dA Significantly Enhanced AMPA Receptor GluR1 S845 Phosphorylation and GluR1, But Not GluR2 Levels at the Synapses</head><p>After 5 days of treatment with drugs, 3'-dA and imipramine enhanced the phosphorylation levels of GluR1 S845 in the PFC and HIP ( <ref type="figure" target="#fig_2">Figure 4D</ref>). We found that both the low and high doses of 3'-dA induced an increase in GluR1 S845 phosphorylation (low dose: 304.01 ± 24.46% in PFC, 244.82 ± 28.91% in HIP; high dose: 285.14 ± 24.54% in PFC, 245.27 ± 26.39% in HIP). Both the low and high doses of 3'-dA induced an increase in GluR1 levels (low dose: 144.12 ± 10.21% in PFC, 129.02 ± 5.04% in HIP; high dose: 152.37 ± 12.47% in PFC, 147.48 ± 10.98% in HIP), but not GluR2 levels, in the PFC and HIP, suggesting that the regulation of 3'-dA to AMPA was subtype-specific. For the imipramine-treated group, chronic treatment resulted in both GluR1 (157.46 ± 7.69% in PFC) and GluR2 (138.01 ± 9.20% in PFC) increases at the synapses, suggesting the regulation is in a GluR1/2 subtype-specific manner, which is different from the 3'-dA regulation ( <ref type="figure" target="#fig_2">Figure 4E and 5B)</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>The Rapid Antidepressant Effect of 3'-dA was Blocked by the AMPA Receptor Specific Antagonist GYKI 52466</head><p>We hypothesized that the AMPA receptor increase is critical for the rapid antidepressant effects of 3'-dA. To determine whether the rapid antidepressant effects of 3'-dA could be blocked by the AMPA receptor-specific antagonist GYKI 52466, we pretreated the mice with 30 mg/kg of GYKI, followed by the i.p. injection of 3'-dA (12.5 mg/kg). The mice were subjected to TST 45 minutes after the 3'-dA injection. The pretreatment of GYKI 52466 almost completely blocked the decrease of immobility time caused by 3'-dA (control: 130.06 ± 11.67 sec; 3'-dA: 65.69 ± 12.02 sec; GYKI + 3'-dA: 122.91 ± 8.65 sec; <ref type="figure" target="#fig_4">Figure 6</ref>), suggesting that enhanced AMPA receptor excitability at the synapses might play an important role in the rapid antidepressant effects of 3'-dA.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p>This study sought to determine the rapid and robust antidepressant effects of 3'-dA and its possible underlying mechanisms in regulating AMPA receptor signaling. We found that: (1) 3'-dA had rapid and robust antidepressant effects in the TST and FST after 45 min of treatment, and this effect remained after 5 days of treatment; (2) unlike the psycho-stimulants, 3'-dA had no hyperactive effect in the OFT; (3) after 45 min of treatment, only high doses of 3'-dA enhanced Phos-GluR1 S845 in the PFC and HIP, and after 5 days of treatment, 3'-dA, similar to imipramine, enhanced Phos-GluR1 S845 in both the PFC and HIP; (4) after 45 min of treatment, only high doses of 3'-dA enhanced Phos-GluR1 S845 and GluR1, but not GluR2 levels, at the synapses in the PFC, and after 5 days of treatment, 3'-dA enhanced Phos-GluR1 S845 and GluR1, but not GluR2 levels, at the synapse in both the PFC and HIP; and (5) AMPA receptor-specific antagonist GYKI 52466 was able to block the rapid and robust antidepressant effects of 3'-dA, suggesting enhanced AMPA synaptic transmission is essential for the rapid antidepressant effects.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>The Rapid and Robust Antidepressant Effect of 3'-dA was Unique to the Psycho-Stimulant Antidepressant Effect</head><p>The most famous rapid antidepressant is ketamine, a noncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist that elicits a rapid antidepressant response in patients with   Rapid and chronic effects of 3 ' -deoxyadenosine (3'-dA) on synaptic GluR2 in the prefrontal cortex (PFC) and hippocampus (HIP). CD-1 mice were i.p. injected with a low dose of 3'-dA (5 mg/kg/day, dA-L), a high dose of 3'-dA (12.5 mg/kg/day, dA-H), imipramine (15mg/kg/day, IMI), or saline (Sal) for 45 minutes or 5 days. Synaptosomal fractions from the PFC or HIP were prepared and subjected to Western blot analyses with anti-GluR2 antibodies. The number of mice per group is indicated in each individual graph. Data were analyzed by one-way ANOVA and presented as mean ± standard error (post hoc Tukey test, ★p &lt; 0.05). (A, B) The expression levels of synaptic GluR2 were not increased in the PFC and HIP after 45-minute or 5-day treatments with 3'-dA.</p><p>depression <ref type="bibr" target="#b5">(Berman et al., 2000;</ref><ref type="bibr" target="#b72">Zarate et al., 2006;</ref><ref type="bibr" target="#b56">Price et al., 2009)</ref> or bipolar depression <ref type="bibr" target="#b15">(DiazGranados et al., 2010;</ref><ref type="bibr" target="#b73">Zarate et al., 2012;</ref><ref type="bibr" target="#b34">Krystal et al., 2013)</ref>. However, ketamine does not present ideal features as an antidepressant because of its potential psychotomimetic effects and abuse. The underlying antidepressant mechanism of ketamine has been well studied, and emerging evidence shows that ketamine's antidepressant properties rely on blocking NMDA receptors, increasing AMPA signaling, and rapidly inducing synaptogenesis <ref type="bibr" target="#b41">(Maeng et al., 2008;</ref><ref type="bibr" target="#b9">Caddy et al., 2014)</ref>. The antidepressant effect of ketamine appears to be fast-acting and lasts for a few days to weeks <ref type="bibr" target="#b0">(Aan Het Rot et al., 2012)</ref>. Some clinical evidence indicates that depressed patients might have side effects of a fast heart rate, high blood pressure, respiratory depression, and hallucinations after treatment with ketamine <ref type="bibr" target="#b8">(Bowdle et al., 1998;</ref><ref type="bibr" target="#b58">Roback et al., 2006;</ref><ref type="bibr" target="#b52">Paul et al., 2009;</ref><ref type="bibr" target="#b1">Aan Het Rot et al., 2010)</ref>. Other psycho-stimulants, such as cocaine and amphetamine, may also have rapid antidepressant effects: however, these psycho-stimulants usually induce excitatory neural toxicity and drug addiction <ref type="bibr" target="#b53">(Pierce and Kalivas, 1997;</ref><ref type="bibr" target="#b45">McCance-Katz et al., 1998)</ref>. Moreover, most psycho-stimulants also lead to the development of depressive symptoms during withdrawal <ref type="bibr" target="#b12">(Che et al., 2013;</ref><ref type="bibr" target="#b35">Krzascik et al., 2015)</ref>.</p><p>3'-dA is an analogue of adenosine, which is a neurotransmitter in the nervous system <ref type="bibr" target="#b26">(Haas and Selbach, 2000)</ref>. It has been shown that adenosine-derived drugs can be transported from blood to the brain via an adenosine transporter across the blood-brain barrier <ref type="bibr" target="#b38">(Li et al., 2001;</ref><ref type="bibr" target="#b51">Pardridge, 2012)</ref>. Very recently, it has been shown that 3'-dA has a beneficial effect in CUMSinduced behavioral deficits after treatment with doses of 20 mg/ kg and 40 mg/kg for 3-6 weeks <ref type="bibr" target="#b66">(Tianzhu et al., 2014)</ref>. Chronic 3'-dA (20, 40 mg/kg) treatments reversed the behavioral deficiency induced by CUMS exposure in the TST and FST <ref type="bibr" target="#b66">(Tianzhu et al., 2014)</ref>. Here, we report a rapid and robust antidepressant effect of 3'-dA alone within a lower dose range (5-12.5 mg/kg). In our study, the 3'-dA resulted in approximately a 45% reduction in immobility time within 45 minutes in both the TST and FST, which is significantly stronger and faster than the traditional antidepressant imipramine ( <ref type="figure">Figure 1A and B)</ref>. The imipramine dose range commonly used for mouse models of depression is 10-20 mg/kg/day <ref type="bibr" target="#b62">(Solomon et al., 2014;</ref><ref type="bibr" target="#b28">Ichikawa et al., 2015)</ref>. We chose the middle of this range, 15 mg/kg, to compare with the similar dose of 3'-dA (12.5 mg/kg) and found that after 45 min of treatment, the imipramine (15 mg/kg) did not reach significant antidepressant effects, but 3'-dA demonstrated faster antidepressant effects <ref type="figure">(Figure 1A and B)</ref>. It is noteworthy that recently evidence has shown that i.p. injection with a low dose of imipramine (&lt;20 mg/kg) did not lead to fast antidepressant effects in 30 minutes, but a dose of 30 or 40 mg/kg decreased the immobility time in mice in the TST and FST <ref type="bibr" target="#b69">(Villard et al., 2011;</ref><ref type="bibr" target="#b10">Cai et al., 2013;</ref><ref type="bibr" target="#b49">Nguyen and Matsumoto, 2015)</ref>. Therefore, we only concluded that compared to the imipramine dose of 15 mg/kg, 3'-dA (12.5 mg/kg) demonstrated faster and stronger antidepressant effects ( <ref type="figure">Figure 1A and B)</ref>. Although 3'-dA demonstrated rapid and strong antidepressant effects, it did not elicit hyperactivity like some of the psycho-stimulants <ref type="figure" target="#fig_0">(Figure 2A</ref> and B).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Consistent with Traditional Antidepressants, 3'-dA Regulated GluR1 S845 Phorsphorylation</head><p>A growing body of data suggests that AMPA receptor signaling plays a critical role in regulating synaptic strength, as well as various forms of neural and behavioral plasticity <ref type="bibr" target="#b11">(Carlezon and Nestler, 2002;</ref><ref type="bibr" target="#b43">Malenka, 2003;</ref><ref type="bibr" target="#b30">Kendell et al., 2005;</ref><ref type="bibr" target="#b60">Rumpel et al., 2005;</ref><ref type="bibr" target="#b63">Sun et al., 2005)</ref>. 3'-dA is an agonist for the adenosine A3 receptor <ref type="bibr" target="#b32">(Kitamura et al., 2011;</ref><ref type="bibr" target="#b47">Nakamura et al., 2015)</ref>, which regulates synaptic plasticity and long-term potentiation in vivo and in vitro <ref type="bibr" target="#b13">(Costenla et al., 2001;</ref><ref type="bibr" target="#b42">Maggi et al., 2009)</ref>. Therefore, we hypothesized that 3'-dA may mediate through the adenosine A3 receptor to regulate the AMPA receptor function, which we will explore in our future research. GluR1 phosphorylation at the S845 site, which is a PKA site, is often viewed as an indicator for GluR1 membrane insertion in neurons and wide channel openings <ref type="bibr" target="#b59">(Roche et al., 1996;</ref><ref type="bibr" target="#b3">Banke et al., 2000;</ref><ref type="bibr" target="#b37">Lee et al., 2000;</ref><ref type="bibr" target="#b23">Esteban et al., 2003)</ref>. A previous study has shown that the levels of GluR1 in the PFCs of depressed patients were decreased <ref type="bibr" target="#b4">(Beneyto et al., 2007)</ref>, which was consistent with the animal experiments <ref type="bibr" target="#b67">(Toth et al., 2008;</ref><ref type="bibr" target="#b71">Yuen et al., 2012;</ref><ref type="bibr" target="#b29">Kallarackal et al., 2013)</ref>. The AMPA receptor may serve as a common mechanism for the treatment of mood disorders, since the two anticonvulsants riluzole (with a predominantly antidepressant profile) and lamotrigine enhanced GluR1 phosphorylation at the S845 site. In contrast, the anticonvulsant valproate (with a predominantly antimanic profile) exerted the opposite effect on GluR1 phosphorylation at the S845 site <ref type="bibr" target="#b17">(Du et al., 2004a</ref><ref type="bibr" target="#b19">(Du et al., , 2007</ref><ref type="bibr" target="#b20">(Du et al., , 2008</ref><ref type="bibr" target="#b21">(Du et al., , 2010</ref><ref type="bibr" target="#b25">Gould et al., 2008)</ref>. Consistent with previous findings, we found that 3'-dA was able to enhance GluR1 S845 phosphorylation and GluR1 synaptic localization in the PFC within 45 minutes ( <ref type="figure" target="#fig_1">Figures 3A and 4B and  C)</ref>, which is faster than the traditional antidepressant imipramine. After 5 days of treatment, both 3'-dA and imipramine were able to enhance the phosphorylation of GluR1 S845 and synaptic GluR1 significantly in the PFC and HIP ( <ref type="figure" target="#fig_1">Figures 3C and 4D and E)</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>3'-dA Modulated GluR1 Synaptic Localization in a Subtype-Specific and Brain Region-Specific Manner</head><p>Previous studies showed that there are three major types of AMPA tetramers in most brain regions: GluR1/2, GluR2/3, and GluR1/3 receptor-specific antagonist GYKI 52466 significantly blocked the 3 ' -deoxyadenosine (3'-dA)-induced rapid antidepressant effect in the tail suspension test (TST). CD-1 mice were i.p. injected with AMPA-specific antagonist GYKI 52466 (30 mg/kg) or vehicle. After 15 minutes, the high dose of 3'-dA or vehicle was also injected. 45 minutes later, the CD-1 mice were subjected to the TST. Immobility time was determined. The number of mice per group is indicated in each individual graph. Data were analyzed by one-way ANOVA and presented as mean ± standard error (post hoc Tukey test, ★p &lt; 0.05, ★★p &lt; 0.01, ★★★p &lt; 0.001). <ref type="bibr" target="#b17">(Du et al., 2004a</ref><ref type="bibr" target="#b18">(Du et al., , 2004b</ref><ref type="bibr" target="#b19">(Du et al., , 2007</ref><ref type="bibr" target="#b20">(Du et al., , 2008</ref><ref type="bibr" target="#b2">Ampuero et al., 2010;</ref><ref type="bibr" target="#b6">Blanco et al., 2012</ref><ref type="bibr" target="#b7">Blanco et al., , 2014</ref>. It has been reported that a traditional antidepressant regulated the GluR1/2 tetramers in the PFC <ref type="bibr" target="#b2">(Ampuero et al., 2010)</ref>. We also found that the chronic treatment of imipramine enhanced GluR1/2 levels at the synapses ( <ref type="figure" target="#fig_2">Figure 4E</ref>), suggesting that imipramine regulates GluR1/2 tetramers of AMPA receptors, which is consistent with previous studies <ref type="bibr" target="#b17">(Du et al., 2004a</ref><ref type="bibr" target="#b18">(Du et al., , 2004b</ref><ref type="bibr" target="#b19">(Du et al., , 2007</ref><ref type="bibr" target="#b20">(Du et al., , 2008</ref>. However, it has been shown that drugs mediating the fast-acting antidepressant mechanisms, like cocaine, regulate the GluR1/3, instead of GluR1/2, in the PFC <ref type="bibr" target="#b6">(Blanco et al., 2012</ref><ref type="bibr" target="#b7">(Blanco et al., , 2014</ref>. 3'-dA did not increase GluR2 levels at the synapses, suggesting that this regulation of increased AMPA synaptic transmission may be mediated through a subtype-specific manner and that other subtypes of AMPA tetramers, such as GluR1/3, might be involved. This is consistent with its fastacting antidepressant effect.</p><p>Previous studies found that PFC was one of the most important brain regions involved in depression. Clinical evidence has demonstrated that neuronal activity in the PFC is reduced in depressed patients, and could be restored by selective serotonin reuptake inhibitor antidepressants <ref type="bibr" target="#b31">(Kennedy et al., 2001;</ref><ref type="bibr" target="#b24">Fales et al., 2009)</ref>. In rodent models, chronic stress decreased the expression levels of AMPA receptors, NMDA receptors, and various synaptic proteins, induced the atrophy of distal dendrites of pyramidal cells, and damaged the dendritic spines in the PFC <ref type="bibr" target="#b40">(Liston et al., 2006;</ref><ref type="bibr" target="#b57">Radley et al., 2008;</ref><ref type="bibr" target="#b39">Li et al., 2011)</ref>. In addition, a recent study showed that the expression levels of GluR1 were decreased in rat PFCs, but not in HIPs after 7 days of chronic restraint stress, suggesting that the PFC is more susceptible to stress <ref type="bibr" target="#b71">(Yuen et al., 2012)</ref>. In this paper, we found that within 45 min, 3'-dA enhanced GluR1 synaptic localization in the PFC ( <ref type="figure" target="#fig_2">Figure 4B</ref>).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>AMPA Receptor Signaling Regulated by 3'-dA Might be Essential for its Rapid and Robust Antidepressant Effect</head><p>A previous study showed that lithium exerts fast (1.5 days) and chronic antidepressant effects in mice TST and FST via upregulating the AMPA receptor subunits GluR1 and GluR2 in the HIP, and an AMPA inhibitor was able to block the antidepressant effect of lithium <ref type="bibr" target="#b25">(Gould et al., 2008)</ref>. In this paper, we found that the effect of 3'-dA on up-regulating AMPA receptor signaling at the synapses might be essential for the rapid antidepressant effects ( <ref type="figure">Figures 1A and B</ref>, 3A, and 4B and C), and AMPA antagonist GYKI 52466 was able to block 3'-dA-induced rapid antidepressant effects ( <ref type="figure" target="#fig_4">Figure 6</ref>). This is consistent with a recent clinical trial showing that Org 26576 (ionotropic AMPA-type glutamate receptor enhancer) significantly improved symptoms in patients diagnosed as depressed by the Montgomery-Asberg Depression Rating Scale <ref type="bibr" target="#b48">(Nations et al., 2012)</ref>.</p><p>3'-dA is the main effective component of Cordyceps Militaris, which has been used as a Chinese herb and food for hundreds of years. Other beneficial effects of 3'-dA, such as the anti-viral and anti-fungal effects, may also provide additional benefits to depressed patients, because viral or fungal infections contribute to or even cause depressive symptoms <ref type="bibr" target="#b68">(Tuli et al., 2013)</ref>. 3'-dA also improves the quality of sleep by increasing non-rapid eye movement sleep <ref type="bibr" target="#b27">(Hu et al., 2013)</ref>. Therefore, 3'-dA is considered relatively safe and beneficial for use as a potential novel antidepressant drug. In summary, in this paper we have identified a rapid and relatively safe antidepressant for the treatment of depression, mediated through enhancing prefrontal AMPA receptor synaptic plasticity. This discovery sheds light on the development of a novel, effective, safe, and rapid drug for the devastating disorder of major depression.</p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Figure 2 .</head><label>2</label><figDesc>An open field test (OFT) of animals after 3 days of treatment with 3 ' -deoxyadenosine (3'-dA). After 3 days of treatment, mice were subjected to the OFT. Total distance traveled and the distance traveled in the center area was determined by automated tracking system. The number of mice per group is indicated in each individual graph. Data were analyzed by one-way ANOVA and presented as mean ± standard error. (A) The total distance traveled in the field after 3'-dA treatment. (B) The distance traveled in the center area of field after 3'-dA treatment. (C) Body weight of the 5 consecutive days after 3'-dA treatment.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Figure 3 .</head><label>3</label><figDesc>Enhanced phosphorylation of GluR1 S845 after 45-minute and 5-day treatments of 3 ' -deoxyadenosine (3'-dA) in the prefrontal cortex (PFC) and hippocampus (HIP). CD-1 mice were i.p. injected with a low dose of 3'-dA (5 mg/kg/day, dA-L), a high dose of 3'-dA (12.5 mg/kg/day, dA-H), imipramine (15mg/kg/day, IMI), or saline (Sal) for 45 minutes or 5 days. Western blot analyses of the proteins from the PFC or HIP were performed with anti-Phos-GluR1 S845 or anti-GluR1 antibodies. The number of mice per group is indicated in each individual graph. Data were analyzed by one-way ANOVA and presented as mean ± standard error (post hoc Tukey test, ★p &lt; 0.05, ★★p &lt; 0.01). (A, B) The expression levels of Phos-GluR1 S845 or GluR1 in both the PFC and HIP after 45 minutes of treatment with 3'-dA. (C, D) The expression levels of Phos-GluR1 S845 and GluR1 in both the PFC and HIP after 5 days of treatment with 3'-dA.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Figure 4 .</head><label>4</label><figDesc>Rapid and chronic effects of 3 ' -deoxyadenosine (3'-dA) on synaptic phosphorylation of GluR1 S845 and GluR1 in the prefrontal cortex (PFC) and hippocampus (HIP). CD-1 mice were i.p. injected with a low dose of 3'-dA (5 mg/kg/day, dA-L), a high dose of 3'-dA (12.5 mg/kg/day, dA-H), imipramine (15mg/kg/ day, IMI), or saline (Sal) for 45 minutes or 5 days. Synaptosomal fractions from the PFC or the HIP were prepared and subjected to Western blot analyses with anti-Phos-GluR1 S845 or anti-GluR1 antibodies. The number of mice per group is indicated in each individual graph. Data were analyzed by one-way ANOVA and presented as mean ± standard error (post hoc Tukey test, ★p &lt; 0.05, ★★p &lt; 0.01, ★★★p &lt; 0.001; two-tail t-test, #p &lt; 0.05, ###p &lt; 0.001). (A) Enrichments of GluR1 and GluR2 at synapses compared with the total protein. (B, C) The expression levels of synaptic Phos-GluR1 S845 and GluR1 were increased in the PFC, but not in the HIP, after 45 minutes of treatment with 3'-dA. (D, E) After 5 days of treatment, 3'-dA enhanced synaptic Phos-GluR1 S845 and GluR1 expressions in both the PFC and HIP.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Figure 5 .</head><label>5</label><figDesc>Figure 5. Rapid and chronic effects of 3 ' -deoxyadenosine (3'-dA) on synaptic GluR2 in the prefrontal cortex (PFC) and hippocampus (HIP). CD-1 mice were i.p. injected</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>Figure 6 .</head><label>6</label><figDesc>The α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA)</figDesc></figure>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgments</head><p>This work was supported by the Yunnan High-Level Professional</p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statement of Interest</head><p>The authors have no conflicts of interest to disclose, financial or otherwise.</p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Ketamine for Depression: Where Do We Go from Here?</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Marije</forename><surname>Aan Het Rot</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Carlos</forename><forename type="middle">A</forename><surname>Zarate</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Dennis</forename><forename type="middle">S</forename><surname>Charney</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sanjay</forename><forename type="middle">J</forename><surname>Mathew</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.biopsych.2012.05.003</idno>
		<idno type="PMID">22705040</idno>
		<idno type="PMCID">PMC3438349</idno>
		<ptr type="open-access" target="http://europepmc.org/articles/pmc3438349?pdf=render" />
	</analytic>
	<monogr>
		<title level="j">Biological Psychiatry</title>
		<title level="j" type="abbrev">Biological Psychiatry</title>
		<idno type="ISSN">0006-3223</idno>
		<imprint>
			<biblScope unit="volume">72</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="537" to="547" />
			<date type="published" when="2012-10" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Safety and Efficacy of Repeated-Dose Intravenous Ketamine for Treatment-Resistant Depression</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Marije</forename><surname>Aan Het Rot</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Katherine</forename><forename type="middle">A</forename><surname>Collins</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">James</forename><forename type="middle">W</forename><surname>Murrough</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Andrew</forename><forename type="middle">M</forename><surname>Perez</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">David</forename><forename type="middle">L</forename><surname>Reich</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Dennis</forename><forename type="middle">S</forename><surname>Charney</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sanjay</forename><forename type="middle">J</forename><surname>Mathew</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.biopsych.2009.08.038</idno>
		<idno type="PMID">19897179</idno>
	</analytic>
	<monogr>
		<title level="j">Biological Psychiatry</title>
		<title level="j" type="abbrev">Biological Psychiatry</title>
		<idno type="ISSN">0006-3223</idno>
		<imprint>
			<biblScope unit="volume">67</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="139" to="145" />
			<date type="published" when="2010-01" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Chronic fluoxetine treatment induces structural plasticity and selective changes in glutamate receptor subunits in the rat cerebral cortex</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>Ampuero</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><forename type="middle">J</forename><surname>Rubio</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Falcon</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Sandoval</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Diaz-Veliz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">E</forename><surname>Gonzalez</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><surname>Earle</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Dagnino-Subiabre</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><surname>Aboitiz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><surname>Orrego</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">U</forename><surname>Wyneken</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.neuroscience.2010.04.035</idno>
		<idno type="PMID">20417256</idno>
	</analytic>
	<monogr>
		<title level="j">Neuroscience</title>
		<title level="j" type="abbrev">Neuroscience</title>
		<idno type="ISSN">0306-4522</idno>
		<imprint>
			<biblScope unit="volume">169</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="98" to="108" />
			<date type="published" when="2010-08" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Control of GluR1 AMPA Receptor Function by cAMP-Dependent Protein Kinase</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><forename type="middle">G</forename><surname>Banke</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Bowie</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H-K</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">L</forename><surname>Huganir</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Schousboe</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">F</forename><surname>Traynelis</surname></persName>
		</author>
		<idno type="DOI">10.1523/jneurosci.20-01-00089.2000</idno>
		<idno type="PMID">10627585</idno>
		<ptr type="open-access" target="http://www.jneurosci.org/content/20/1/89.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">The Journal of Neuroscience</title>
		<title level="j" type="abbrev">J. Neurosci.</title>
		<idno type="ISSN">0270-6474</idno>
		<idno type="ISSNe">1529-2401</idno>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="89" to="102" />
			<date type="published" when="2000-01-01" />
			<publisher>Society for Neuroscience</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Abnormal Glutamate Receptor Expression in the Medial Temporal Lobe in Schizophrenia and Mood Disorders</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Monica</forename><surname>Beneyto</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Lars</forename><forename type="middle">V</forename><surname>Kristiansen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Akinwunmi</forename><surname>Oni-Orisan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Robert</forename><forename type="middle">E</forename><surname>Mccullumsmith</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">James</forename><forename type="middle">H</forename><surname>Meador-Woodruff</surname></persName>
		</author>
		<idno type="DOI">10.1038/sj.npp.1301312</idno>
		<idno type="PMID">17299517</idno>
		<ptr type="open-access" target="https://www.nature.com/articles/1301312.pdf" />
	</analytic>
	<monogr>
		<title level="j">Neuropsychopharmacology</title>
		<title level="j" type="abbrev">Neuropsychopharmacol</title>
		<idno type="ISSN">0893-133X</idno>
		<idno type="ISSNe">1740-634X</idno>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="1888" to="1902" />
			<date type="published" when="2007-02-14" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Antidepressant effects of ketamine in depressed patients</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Robert</forename><forename type="middle">M</forename><surname>Berman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Angela</forename><surname>Cappiello</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Amit</forename><surname>Anand</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Dan</forename><forename type="middle">A</forename><surname>Oren</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">George</forename><forename type="middle">R</forename><surname>Heninger</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Dennis</forename><forename type="middle">S</forename><surname>Charney</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">John</forename><forename type="middle">H</forename><surname>Krystal</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0006-3223(99)00230-9</idno>
		<idno type="PMID">10686270</idno>
		<idno type="PII">S0006-3223(99)00230-9</idno>
		<idno type="ark">ark:/67375/6H6-KSCH6643-5</idno>
		<idno type="istexId">9B541F29A5F1FA2AEC31C751EF90B36FA47DE030</idno>
	</analytic>
	<monogr>
		<title level="j">Biological Psychiatry</title>
		<title level="j" type="abbrev">Biological Psychiatry</title>
		<idno type="ISSN">0006-3223</idno>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="351" to="354" />
			<date type="published" when="2000-02" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Attenuation of cocaine-induced conditioned locomotion is associated with altered expression of hippocampal glutamate receptors in mice lacking LPA1 receptors</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Eduardo</forename><surname>Blanco</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ainhoa</forename><surname>Bilbao</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">María</forename><forename type="middle">Jesús</forename><surname>Luque‐rojas</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ana</forename><surname>Palomino</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Francisco</forename><forename type="middle">J</forename><surname>Bermúdez-Silva</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Juan</forename><surname>Suárez</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Luis</forename><forename type="middle">J</forename><surname>Santín</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Guillermo</forename><surname>Estivill-Torrús</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Antonia</forename><surname>Gutiérrez</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">José</forename><forename type="middle">Ángel</forename><surname>Campos-Sandoval</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Francisco</forename><forename type="middle">J</forename><surname>Alonso-Carrión</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Javier</forename><surname>Márquez</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Fernando</forename><forename type="middle">Rodríguez</forename><surname>De Fonseca</surname></persName>
		</author>
		<idno type="DOI">10.1007/s00213-011-2446-6</idno>
		<idno type="PMID">21887497</idno>
		<idno type="ark">ark:/67375/VQC-KRXV8JGW-R</idno>
		<idno type="istexId">0043638651BF2F0ABF959FD2ABFC7335EFF7D5BB</idno>
	</analytic>
	<monogr>
		<title level="j">Psychopharmacology</title>
		<title level="j" type="abbrev">Psychopharmacology</title>
		<idno type="ISSN">0033-3158</idno>
		<idno type="ISSNe">1432-2072</idno>
		<imprint>
			<biblScope unit="volume">220</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="27" to="42" />
			<date type="published" when="2011-09-02" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Cocaine-Induced Behavioral Sensitization Is Associated With Changes in the Expression of Endocannabinoid and Glutamatergic Signaling Systems in the Mouse Prefrontal Cortex</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Eduardo</forename><surname>Blanco</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Francisco</forename><forename type="middle">J</forename><surname>Pavón</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ana</forename><surname>Palomino</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">María</forename><forename type="middle">Jesús</forename><surname>Luque-Rojas</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Antonia</forename><surname>Serrano</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Patricia</forename><surname>Rivera</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ainhoa</forename><surname>Bilbao</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Francisco</forename><surname>Alen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Margarita</forename><surname>Vida</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Juan</forename><surname>Suárez</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Fernando</forename><surname>Rodríguez De Fonseca</surname></persName>
		</author>
		<idno type="DOI">10.1093/ijnp/pyu024</idno>
		<idno type="PMID">25539508</idno>
		<idno type="PMCID">PMC4368868</idno>
		<ptr type="open-access" target="http://europepmc.org/articles/pmc4368868?pdf=render" />
	</analytic>
	<monogr>
		<title level="j">International Journal of Neuropsychopharmacology</title>
		<idno type="ISSN">1461-1457</idno>
		<idno type="ISSNe">1469-5111</idno>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="issue">1</biblScope>
			<date type="published" when="2014-12-20" />
			<publisher>Oxford University Press (OUP)</publisher>
		</imprint>
	</monogr>
	<note>in the mouse prefrontal cortex</note>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Psychedelic effects of ketamine in healthy volunteers: relationship to steady-state plasma concentrations</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><forename type="middle">A</forename><surname>Bowdle</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">D</forename><surname>Radant</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">S</forename><surname>Cowley</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><forename type="middle">D</forename><surname>Kharasch</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">J</forename><surname>Strassman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">P</forename><surname>Roy-Byrne</surname></persName>
		</author>
		<idno type="DOI">10.1093/ijnp/pyu024</idno>
	</analytic>
	<monogr>
		<title level="j">Int J Neuropsychop</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="82" to="88" />
			<date type="published" when="1998" />
		</imprint>
	</monogr>
	<note>Anesthesiology</note>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Ketamine as the prototype glutamatergic antidepressant: pharmacodynamic actions, and a systematic review and meta-analysis of efficacy</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Caroline</forename><surname>Caddy</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Giovanni</forename><surname>Giaroli</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Thomas</forename><forename type="middle">P</forename><surname>White</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sukhwinder</forename><forename type="middle">S</forename><surname>Shergill</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Derek</forename><forename type="middle">K</forename><surname>Tracy</surname></persName>
		</author>
		<idno type="DOI">10.1177/2045125313507739</idno>
		<idno type="PMID">24688759</idno>
		<idno type="PMCID">PMC3952483</idno>
		<ptr type="open-access" target="http://journals.sagepub.com/doi/pdf/10.1177/2045125313507739" />
	</analytic>
	<monogr>
		<title level="j">Therapeutic Advances in Psychopharmacology</title>
		<title level="j" type="abbrev">Therapeutic Advances in</title>
		<idno type="ISSN">2045-1253</idno>
		<idno type="ISSNe">2045-1261</idno>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="75" to="99" />
			<date type="published" when="2013-10-22" />
			<publisher>SAGE Publications</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Local potentiation of excitatory synapses by serotonin and its alteration in rodent models of depression</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Xiang</forename><surname>Cai</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Angy</forename><forename type="middle">J</forename><surname>Kallarackal</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mark</forename><forename type="middle">D</forename><surname>Kvarta</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sasha</forename><surname>Goluskin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kaitlin</forename><surname>Gaylor</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Aileen</forename><forename type="middle">M</forename><surname>Bailey</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hey-Kyoung</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Richard</forename><forename type="middle">L</forename><surname>Huganir</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Scott</forename><forename type="middle">M</forename><surname>Thompson</surname></persName>
		</author>
		<idno type="DOI">10.1038/nn.3355</idno>
		<idno type="PMID">23502536</idno>
		<idno type="PMCID">PMC3609911</idno>
		<ptr type="open-access" target="http://europepmc.org/articles/pmc3609911?pdf=render" />
	</analytic>
	<monogr>
		<title level="j">Nature Neuroscience</title>
		<title level="j" type="abbrev">Nat Neurosci</title>
		<idno type="ISSN">1097-6256</idno>
		<idno type="ISSNe">1546-1726</idno>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="464" to="472" />
			<date type="published" when="2013-03-17" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Elevated levels of GluR1 in the midbrain: a trigger for sensitization to drugs of abuse?</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">William</forename><forename type="middle">A</forename><surname>Carlezon</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ericj.</forename><surname>Nestler</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0166-2236(02)02289-0</idno>
		<idno type="PMID">12446127</idno>
	</analytic>
	<monogr>
		<title level="j">Trends in Neurosciences</title>
		<title level="j" type="abbrev">Trends in Neurosciences</title>
		<idno type="ISSN">0166-2236</idno>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="610" to="615" />
			<date type="published" when="2002-12" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Abstinence from repeated amphetamine treatment induces depressive-like behaviors and oxidative damage in rat brain</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yi</forename><surname>Che</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yong-Hua</forename><surname>Cui</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hua</forename><surname>Tan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ana</forename><forename type="middle">C</forename><surname>Andreazza</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">Trevor</forename><surname>Young</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jun-Feng</forename><surname>Wang</surname></persName>
		</author>
		<idno type="DOI">10.1007/s00213-013-2993-0</idno>
		<idno type="PMID">23371493</idno>
		<idno type="ark">ark:/67375/VQC-9CR83T6T-9</idno>
		<idno type="istexId">FD44195B9923824E42AFE7E43D07314CEE7B7BA2</idno>
	</analytic>
	<monogr>
		<title level="j">Psychopharmacology</title>
		<title level="j" type="abbrev">Psychopharmacology</title>
		<idno type="ISSN">0033-3158</idno>
		<idno type="ISSNe">1432-2072</idno>
		<imprint>
			<biblScope unit="volume">227</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="605" to="614" />
			<date type="published" when="2013-02-01" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">A functional role for adenosine A3 receptors: modulation of synaptic plasticity in the rat hippocampus</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ana</forename><forename type="middle">Rita</forename><surname>Costenla</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Luı́sa</forename><forename type="middle">V</forename><surname>Lopes</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Alexandre</forename><surname>De Mendonça</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Joaquim</forename><forename type="middle">A</forename><surname>Ribeiro</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0304-3940(01)01633-0</idno>
		<idno type="PMID">11278110</idno>
		<idno type="PII">S0304-3940(01)01633-0</idno>
		<idno type="ark">ark:/67375/6H6-2CFCL40G-L</idno>
		<idno type="istexId">D7C425B671C0F806B604F10DC92E01351FFE5AFC</idno>
	</analytic>
	<monogr>
		<title level="j">Neuroscience Letters</title>
		<title level="j" type="abbrev">Neuroscience Letters</title>
		<idno type="ISSN">0304-3940</idno>
		<imprint>
			<biblScope unit="volume">302</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="53" to="57" />
			<date type="published" when="2001-04" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Relationship Between Anticonvulsant Activity and Plasma Level of Some 2,3-Benzodiazepines in Genetically Epilepsy-Prone Rats</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">De</forename><surname>Sarro</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Rizzo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Sinopoli</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">V</forename><forename type="middle">A</forename><surname>Gitto</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">De</forename><surname>Sarro</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Zappala</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Chimirri</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename></persName>
		</author>
		<idno type="DOI">10.1016/s0091-3057(98)00036-7</idno>
		<idno type="PMID">9768555</idno>
		<idno type="PII">S0091-3057(98)00036-7</idno>
		<idno type="ark">ark:/67375/6H6-Z8T65GH7-W</idno>
		<idno type="istexId">AE54834CD55EC654D1E6296CE3A24B42B8B8BED3</idno>
	</analytic>
	<monogr>
		<title level="j">Pharmacology Biochemistry and Behavior</title>
		<idno type="ISSN">0091-3057</idno>
		<imprint>
			<biblScope unit="volume">61</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="215" to="220" />
			<date type="published" when="1998-11" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Rapid Resolution of Suicidal Ideation After a Single Infusion of anN-Methyl-D-Aspartate Antagonist in Patients With Treatment-Resistant Major Depressive Disorder</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Nancy</forename><surname>Diazgranados</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Lobna</forename><forename type="middle">A</forename><surname>Ibrahim</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Nancy</forename><forename type="middle">E</forename><surname>Brutsche</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Rezvan</forename><surname>Ameli</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ioline</forename><forename type="middle">D</forename><surname>Henter</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">David</forename><forename type="middle">A</forename><surname>Luckenbaugh</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Rodrigo</forename><surname>Machado-Vieira</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Carlos</forename><forename type="middle">A</forename><surname>Zarate</surname></persName>
		</author>
		<idno type="DOI">10.4088/jcp.09m05327blu</idno>
		<idno type="PMID">20673547</idno>
		<idno type="PMCID">PMC3012738</idno>
		<ptr type="open-access" target="http://europepmc.org/articles/pmc3012738?pdf=render" />
	</analytic>
	<monogr>
		<title level="j">The Journal of Clinical Psychiatry</title>
		<title level="j" type="abbrev">J. Clin. Psychiatry</title>
		<idno type="ISSN">0160-6689</idno>
		<imprint>
			<biblScope unit="volume">71</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="1605" to="1611" />
			<date type="published" when="2010-07-13" />
			<publisher>Physicians Postgraduate Press, Inc</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Mapping the Matrix: The Ways of Neocortex</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Rodney</forename><forename type="middle">J</forename><surname>Douglas</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kevan</forename><forename type="middle">A C</forename><surname>Martin</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.neuron.2007.10.017</idno>
		<idno type="PMID">17964242</idno>
	</analytic>
	<monogr>
		<title level="j">Neuron</title>
		<title level="j" type="abbrev">Neuron</title>
		<idno type="ISSN">0896-6273</idno>
		<imprint>
			<biblScope unit="volume">56</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="226" to="238" />
			<date type="published" when="2007-10" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Modulation of Synaptic Plasticity by Antimanic Agents: The Role of AMPA Glutamate Receptor Subunit 1 Synaptic Expression</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Du</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><forename type="middle">A</forename><surname>Gray</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">A</forename><surname>Falke</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Yuan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">T</forename><surname>Szabo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Einat</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><forename type="middle">K</forename><surname>Manji</surname></persName>
		</author>
		<idno type="DOI">10.1523/jneurosci.1258-04.2004</idno>
		<idno type="PMID">15269270</idno>
		<ptr type="open-access" target="http://www.jneurosci.org/content/24/29/6578.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Journal of Neuroscience</title>
		<title level="j" type="abbrev">Journal of Neuroscience</title>
		<idno type="ISSN">0270-6474</idno>
		<idno type="ISSNe">1529-2401</idno>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="issue">29</biblScope>
			<biblScope unit="page" from="6578" to="6589" />
			<date type="published" when="2004-07-21" />
			<publisher>Society for Neuroscience</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Bipolar disorder: involvement of signaling cascades and AMPA receptor trafficking at synapses</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jing</forename><surname>Du</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jorge</forename><surname>Quiroz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Peixiong</forename><surname>Yuan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Carlos</forename><surname>Zarate</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Husseini</forename><forename type="middle">K</forename><surname>Manji</surname></persName>
		</author>
		<idno type="DOI">10.1017/s1740925x05000098</idno>
		<idno type="PMID">18634600</idno>
		<idno type="PMCID">PMC2763507</idno>
		<ptr type="open-access" target="http://europepmc.org/articles/pmc2763507?pdf=render" />
	</analytic>
	<monogr>
		<title level="j">Neuron Glia Biology</title>
		<title level="j" type="abbrev">NGB</title>
		<idno type="ISSN">1740-925X</idno>
		<idno type="ISSNe">1741-0533</idno>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="issue">03</biblScope>
			<biblScope unit="page" from="231" to="243" />
			<date type="published" when="2004-08" />
			<publisher>Cambridge University Press (CUP)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">The Anticonvulsants Lamotrigine, Riluzole, and Valproate Differentially Regulate AMPA Receptor Membrane Localization: Relationship to Clinical Effects in Mood Disorders</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jing</forename><surname>Du</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Katsuji</forename><surname>Suzuki</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yanling</forename><surname>Wei</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yun</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Rayah</forename><surname>Blumenthal</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Zheng</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Cynthia</forename><surname>Falke</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Carlos</forename><forename type="middle">A</forename><surname>Zarate</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Husseini</forename><forename type="middle">K</forename><surname>Manji</surname></persName>
		</author>
		<idno type="DOI">10.1038/sj.npp.1301178</idno>
		<idno type="PMID">16936714</idno>
		<ptr type="open-access" target="https://www.nature.com/articles/1301178.pdf" />
	</analytic>
	<monogr>
		<title level="j">Neuropsychopharmacology</title>
		<title level="j" type="abbrev">Neuropsychopharmacology</title>
		<idno type="ISSN">0893-133X</idno>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="793" to="802" />
			<date type="published" when="2006-08-16" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">The Role of Hippocampal GluR1 and GluR2 Receptors in Manic-Like Behavior</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Du</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><forename type="middle">K</forename><surname>Creson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L-J</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Ren</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><forename type="middle">A</forename><surname>Gray</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Falke</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Wei</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Blumenthal</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Machado-Vieira</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Yuan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Zhuo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><forename type="middle">K</forename><surname>Manji</surname></persName>
		</author>
		<idno type="DOI">10.1523/jneurosci.3080-07.2008</idno>
		<idno type="PMID">18171924</idno>
		<idno type="PMCID">PMC2763546</idno>
		<ptr type="open-access" target="http://www.jneurosci.org/content/28/1/68.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Journal of Neuroscience</title>
		<title level="j" type="abbrev">Journal of Neuroscience</title>
		<idno type="ISSN">0270-6474</idno>
		<idno type="ISSNe">1529-2401</idno>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="68" to="79" />
			<date type="published" when="2008-01-02" />
			<publisher>Society for Neuroscience</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">A kinesin signaling complex mediates the ability of GSK-3 to affect mood-associated behaviors</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Du</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Wei</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Khairova</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Blumenthal</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Tragon</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">G</forename><surname>Hunsberger</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Machado-Vieira</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><surname>Drevets</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><forename type="middle">T</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><forename type="middle">K</forename><surname>Manji</surname></persName>
		</author>
		<idno type="DOI">10.1073/pnas.0913138107</idno>
		<idno type="PMID">20534517</idno>
		<idno type="PMCID">PMC2895136</idno>
		<ptr type="open-access" target="http://europepmc.org/articles/pmc2895136?pdf=render" />
	</analytic>
	<monogr>
		<title level="j">Proceedings of the National Academy of Sciences</title>
		<title level="j" type="abbrev">Proceedings of the National Academy of Sciences</title>
		<idno type="ISSN">0027-8424</idno>
		<idno type="ISSNe">1091-6490</idno>
		<imprint>
			<biblScope unit="volume">107</biblScope>
			<biblScope unit="issue">25</biblScope>
			<biblScope unit="page" from="11573" to="11578" />
			<date type="published" when="2010-06-07" />
			<publisher>Proceedings of the National Academy of Sciences</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Altered expression of synapse and glutamate related genes in post-mortem hippocampus of depressed subjects</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Vanja</forename><surname>Duric</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mounira</forename><surname>Banasr</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Craig</forename><forename type="middle">A</forename><surname>Stockmeier</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Arthur</forename><forename type="middle">A</forename><surname>Simen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Samuel</forename><forename type="middle">S</forename><surname>Newton</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">James</forename><forename type="middle">C</forename><surname>Overholser</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">George</forename><forename type="middle">J</forename><surname>Jurjus</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Lesa</forename><surname>Dieter</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ronald</forename><forename type="middle">S</forename><surname>Duman</surname></persName>
		</author>
		<idno type="DOI">10.1017/s1461145712000016</idno>
		<idno type="PMID">22339950</idno>
		<idno type="PMCID">PMC3414647</idno>
		<ptr type="open-access" target="https://academic.oup.com/ijnp/article-pdf/16/1/69/1755392/16-1-69.pdf" />
	</analytic>
	<monogr>
		<title level="j">The International Journal of Neuropsychopharmacology</title>
		<title level="j" type="abbrev">Int. J. Neuropsychopharm.</title>
		<idno type="ISSN">1461-1457</idno>
		<idno type="ISSNe">1469-5111</idno>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="issue">01</biblScope>
			<biblScope unit="page" from="69" to="82" />
			<date type="published" when="2012-02-17" />
			<publisher>Oxford University Press (OUP)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">PKA phosphorylation of AMPA receptor subunits controls synaptic trafficking underlying plasticity</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">José</forename><forename type="middle">A</forename><surname>Esteban</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Song-Hai</forename><surname>Shi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Christopher</forename><surname>Wilson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mutsuo</forename><surname>Nuriya</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Richard</forename><forename type="middle">L</forename><surname>Huganir</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Roberto</forename><surname>Malinow</surname></persName>
		</author>
		<idno type="DOI">10.1038/nn997</idno>
		<idno type="PMID">12536214</idno>
	</analytic>
	<monogr>
		<title level="j">Nature Neuroscience</title>
		<title level="j" type="abbrev">Nat Neurosci</title>
		<idno type="ISSN">1097-6256</idno>
		<idno type="ISSNe">1546-1726</idno>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="136" to="143" />
			<date type="published" when="2003-01-21" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Antidepressant treatment normalizes hypoactivity in dorsolateral prefrontal cortex during emotional interference processing in major depression</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Christina</forename><forename type="middle">L</forename><surname>Fales</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Deanna</forename><forename type="middle">M</forename><surname>Barch</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Melissa</forename><forename type="middle">M</forename><surname>Rundle</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mark</forename><forename type="middle">A</forename><surname>Mintun</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jose</forename><surname>Mathews</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Abraham</forename><forename type="middle">Z</forename><surname>Snyder</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yvette</forename><forename type="middle">I</forename><surname>Sheline</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jad.2008.04.027</idno>
		<idno type="PMID">18559283</idno>
		<idno type="PMCID">PMC2825146</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of Affective Disorders</title>
		<title level="j" type="abbrev">Journal of Affective Disorders</title>
		<idno type="ISSN">0165-0327</idno>
		<imprint>
			<biblScope unit="volume">112</biblScope>
			<biblScope unit="issue">1-3</biblScope>
			<biblScope unit="page" from="206" to="211" />
			<date type="published" when="2009-01" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Involvement of AMPA receptors in the antidepressant-like effects of lithium in the mouse tail suspension test and forced swim test</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Todd</forename><forename type="middle">D</forename><surname>Gould</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kelley</forename><forename type="middle">C</forename><surname>O'donnell</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Eliot</forename><forename type="middle">R</forename><surname>Dow</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jing</forename><surname>Du</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Guang</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Husseini</forename><forename type="middle">K</forename><surname>Manji</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.neuropharm.2007.11.002</idno>
		<idno type="PMID">18096191</idno>
		<idno type="PMCID">PMC2275050</idno>
		<ptr type="open-access" target="http://europepmc.org/articles/pmc2275050?pdf=render" />
	</analytic>
	<monogr>
		<title level="j">Neuropharmacology</title>
		<title level="j" type="abbrev">Neuropharmacology</title>
		<idno type="ISSN">0028-3908</idno>
		<imprint>
			<biblScope unit="volume">54</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="577" to="587" />
			<date type="published" when="2008-03" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Functions of neuronal adenosine receptors</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Helmut</forename><forename type="middle">L</forename><surname>Haas</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Oliver</forename><surname>Selbach</surname></persName>
		</author>
		<idno type="DOI">10.1007/s002100000314</idno>
		<idno type="PMID">11111831</idno>
		<idno type="ark">ark:/67375/VQC-W5QVM995-T</idno>
		<idno type="istexId">01AD52335A159B4B0994EEA067FD100943BCA05A</idno>
	</analytic>
	<monogr>
		<title level="j">Naunyn-Schmiedeberg&apos;s Archives of Pharmacology</title>
		<title level="j" type="abbrev">Naunyn-Schmied Arch Pharmacol</title>
		<idno type="ISSN">0028-1298</idno>
		<idno type="ISSNe">1432-1912</idno>
		<imprint>
			<biblScope unit="volume">362</biblScope>
			<biblScope unit="issue">4-5</biblScope>
			<biblScope unit="page" from="375" to="381" />
			<date type="published" when="2000-08-17" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Cordycepin Increases Nonrapid Eye Movement Sleep via Adenosine Receptors in Rats</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Zhenzhen</forename><surname>Hu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Chung-Il</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Vikash</forename><forename type="middle">Kumar</forename><surname>Shah</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Eun-Hye</forename><surname>Oh</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jin-Yi</forename><surname>Han</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jae-Ryong</forename><surname>Bae</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kinam</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Myong-Soo</forename><surname>Chong</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jin</forename><forename type="middle">Tae</forename><surname>Hong</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ki-Wan</forename><surname>Oh</surname></persName>
		</author>
		<idno type="DOI">10.1155/2013/840134</idno>
		<idno type="PMID">23710239</idno>
		<idno type="PMCID">PMC3655593</idno>
		<ptr type="open-access" target="http://downloads.hindawi.com/journals/ecam/2013/840134.pdf" />
	</analytic>
	<monogr>
		<title level="j">Evidence-Based Complementary and Alternative Medicine</title>
		<title level="j" type="abbrev">Evidence-Based Complementary and Alternative Medicine</title>
		<idno type="ISSN">1741-427X</idno>
		<idno type="ISSNe">1741-4288</idno>
		<imprint>
			<biblScope unit="volume">2013</biblScope>
			<biblScope unit="page" from="1" to="8" />
			<date type="published" when="2013" />
			<publisher>Hindawi Limited</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">The loss of NDRG2 expression improves depressive behavior through increased phosphorylation of GSK3β</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tomonaga</forename><surname>Ichikawa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Shingo</forename><surname>Nakahata</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tomohiro</forename><surname>Tamura</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Nawin</forename><surname>Manachai</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kazuhiro</forename><surname>Morishita</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.cellsig.2015.07.012</idno>
		<idno type="PMID">26208882</idno>
	</analytic>
	<monogr>
		<title level="j">Cellular Signalling</title>
		<title level="j" type="abbrev">Cellular Signalling</title>
		<idno type="ISSN">0898-6568</idno>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="2087" to="2098" />
			<date type="published" when="2015-10" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Chronic Stress Induces a Selective Decrease in AMPA Receptor-Mediated Synaptic Excitation at Hippocampal Temporoammonic-CA1 Synapses</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">J</forename><surname>Kallarackal</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">D</forename><surname>Kvarta</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>Cammarata</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Jaberi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">X</forename><surname>Cai</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">M</forename><surname>Bailey</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">M</forename><surname>Thompson</surname></persName>
		</author>
		<idno type="DOI">10.1523/jneurosci.2588-13.2013</idno>
		<idno type="PMID">24089474</idno>
		<idno type="PMCID">PMC3787493</idno>
		<ptr type="open-access" target="https://www.jneurosci.org/content/jneuro/33/40/15669.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Journal of Neuroscience</title>
		<title level="j" type="abbrev">Journal of Neuroscience</title>
		<idno type="ISSN">0270-6474</idno>
		<idno type="ISSNe">1529-2401</idno>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="issue">40</biblScope>
			<biblScope unit="page" from="15669" to="15674" />
			<date type="published" when="2013-10-02" />
			<publisher>Society for Neuroscience</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">GABA and glutamate systems as therapeutic targets in depression and mood disorders</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Steven</forename><forename type="middle">F</forename><surname>Kendell</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">John</forename><forename type="middle">H</forename><surname>Krystal</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Gerrard</forename><surname>Sanacora</surname></persName>
		</author>
		<idno type="DOI">10.1517/14728222.9.1.153</idno>
		<idno type="PMID">15757488</idno>
	</analytic>
	<monogr>
		<title level="j">Expert Opinion on Therapeutic Targets</title>
		<title level="j" type="abbrev">Expert Opinion on Therapeutic Targets</title>
		<idno type="ISSN">1472-8222</idno>
		<idno type="ISSNe">1744-7631</idno>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="153" to="168" />
			<date type="published" when="2005-02" />
			<publisher>Informa Healthcare</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Changes in Regional Brain Glucose Metabolism Measured With Positron Emission Tomography After Paroxetine Treatment of Major Depression</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sidney</forename><forename type="middle">H</forename><surname>Kennedy</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kenneth</forename><forename type="middle">R</forename><surname>Evans</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Stephanie</forename><surname>Krüger</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Helen</forename><forename type="middle">S</forename><surname>Mayberg</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jeffrey</forename><forename type="middle">H</forename><surname>Meyer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sonia</forename><surname>Mccann</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Andrew</forename><forename type="middle">I</forename><surname>Arifuzzman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sylvain</forename><surname>Houle</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Franco</forename><forename type="middle">J</forename><surname>Vaccarino</surname></persName>
		</author>
		<idno type="DOI">10.1176/appi.ajp.158.6.899</idno>
		<idno type="PMID">11384897</idno>
	</analytic>
	<monogr>
		<title level="j">American Journal of Psychiatry</title>
		<title level="j" type="abbrev">AJP</title>
		<idno type="ISSN">0002-953X</idno>
		<idno type="ISSNe">1535-7228</idno>
		<imprint>
			<biblScope unit="volume">158</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="899" to="905" />
			<date type="published" when="2001-06" />
			<publisher>American Psychiatric Publishing</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Aberrant, differential and bidirectional regulation of the unfolded protein response towards cell survival by 3′-deoxyadenosine</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Kitamura</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Kato</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Saito</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Nakajima</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Takahashi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Johno</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Gu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Katoh</surname></persName>
		</author>
		<idno type="DOI">10.1038/cdd.2011.63</idno>
		<idno type="PMID">21597460</idno>
		<idno type="PMCID">PMC3214911</idno>
		<ptr type="open-access" target="https://www.nature.com/articles/cdd201163.pdf" />
	</analytic>
	<monogr>
		<title level="j">Cell Death &amp; Differentiation</title>
		<title level="j" type="abbrev">Cell Death Differ</title>
		<idno type="ISSN">1350-9047</idno>
		<idno type="ISSNe">1476-5403</idno>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="1876" to="1888" />
			<date type="published" when="2011-05-20" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">H</forename><surname>Krystal</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Sanacora</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Blumberg</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Anand</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">S</forename><surname>Charney</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Marek</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">N</forename><surname>Epperson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Goddard</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><forename type="middle">F</forename><surname>Mason</surname></persName>
		</author>
		<idno type="DOI">10.1038/sj.mp.4001021</idno>
		<idno type="PMID">11986998</idno>
		<ptr type="open-access" target="https://www.nature.com/articles/4001021.pdf" />
	</analytic>
	<monogr>
		<title level="j">Molecular Psychiatry</title>
		<title level="j" type="abbrev">Mol Psychiatry</title>
		<idno type="ISSN">1359-4184</idno>
		<idno type="ISSNe">1476-5578</idno>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="issue">S1</biblScope>
			<biblScope unit="page" from="S71" to="S80" />
			<date type="published" when="2002-01" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
	<note>Suppl</note>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Rapid-Acting Glutamatergic Antidepressants: The Path to Ketamine and Beyond</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">John</forename><forename type="middle">H</forename><surname>Krystal</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Gerard</forename><surname>Sanacora</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ronald</forename><forename type="middle">S</forename><surname>Duman</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.biopsych.2013.03.026</idno>
		<idno type="PMID">23726151</idno>
		<idno type="PMCID">PMC3671489</idno>
		<ptr type="open-access" target="http://europepmc.org/articles/pmc3671489?pdf=render" />
	</analytic>
	<monogr>
		<title level="j">Biological Psychiatry</title>
		<title level="j" type="abbrev">Biological Psychiatry</title>
		<idno type="ISSN">0006-3223</idno>
		<imprint>
			<biblScope unit="volume">73</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="1133" to="1141" />
			<date type="published" when="2013-06" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">The neurosteroid dehydroepiandrosterone sulfate, but not androsterone, enhances the antidepressant effect of cocaine examined in the forced swim test — Possible role of serotonergic neurotransmission</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Pawel</forename><surname>Krzascik</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Malgorzata</forename><forename type="middle">Elzbieta</forename><surname>Zajda</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Maria</forename><forename type="middle">Dorota</forename><surname>Majewska</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.yhbeh.2014.12.012</idno>
		<idno type="PMID">25747464</idno>
	</analytic>
	<monogr>
		<title level="j">Hormones and Behavior</title>
		<title level="j" type="abbrev">Hormones and Behavior</title>
		<idno type="ISSN">0018-506X</idno>
		<imprint>
			<biblScope unit="volume">70</biblScope>
			<biblScope unit="page" from="64" to="72" />
			<date type="published" when="2015-04" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Adolescent amphetamine exposure elicits dose-specific effects on monoaminergic neurotransmission and behaviour in adulthood</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Benoit</forename><surname>Labonte</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ryan</forename><forename type="middle">J</forename><surname>Mclaughlin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sergio</forename><surname>Dominguez-Lopez</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Francis</forename><forename type="middle">Rodriguez</forename><surname>Bambico</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ilaria</forename><surname>Lucchino</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Rafael</forename><surname>Ochoa-Sanchez</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Marco</forename><surname>Leyton</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Gabriella</forename><surname>Gobbi</surname></persName>
		</author>
		<idno type="DOI">10.1017/s1461145711001544</idno>
		<idno type="PMID">22053980</idno>
		<ptr type="open-access" target="https://academic.oup.com/ijnp/article-pdf/15/9/1319/1953418/15-9-1319.pdf" />
	</analytic>
	<monogr>
		<title level="j">The International Journal of Neuropsychopharmacology</title>
		<title level="j" type="abbrev">Int. J. Neuropsychopharm.</title>
		<idno type="ISSN">1461-1457</idno>
		<idno type="ISSNe">1469-5111</idno>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="issue">09</biblScope>
			<biblScope unit="page" from="1319" to="1330" />
			<date type="published" when="2011-11-03" />
			<publisher>Oxford University Press (OUP)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Regulation of distinct AMPA receptor phosphorylation sites during bidirectional synaptic plasticity</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hey-Kyoung</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Michaela</forename><surname>Barbarosie</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kimihiko</forename><surname>Kameyama</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mark</forename><forename type="middle">F</forename><surname>Bear</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Richard</forename><forename type="middle">L</forename><surname>Huganir</surname></persName>
		</author>
		<idno type="DOI">10.1038/35016089</idno>
		<idno type="PMID">10879537</idno>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<title level="j" type="abbrev">Nature</title>
		<idno type="ISSN">0028-0836</idno>
		<idno type="ISSNe">1476-4687</idno>
		<imprint>
			<biblScope unit="volume">405</biblScope>
			<biblScope unit="issue">6789</biblScope>
			<biblScope unit="page" from="955" to="959" />
			<date type="published" when="2000-06" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Cloned Blood–Brain Barrier Adenosine Transporter is Identical to the Rat Concentrative Na+ Nucleoside Cotransporter CNT2</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jian</forename><forename type="middle">Yi</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ruben</forename><forename type="middle">J</forename><surname>Boado</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">William</forename><forename type="middle">M</forename><surname>Pardridge</surname></persName>
		</author>
		<idno type="DOI">10.1097/00004647-200108000-00005</idno>
		<idno type="PMID">11487728</idno>
		<ptr type="open-access" target="https://journals.sagepub.com/doi/pdf/10.1097/00004647-200108000-00005" />
	</analytic>
	<monogr>
		<title level="j">Journal of Cerebral Blood Flow &amp; Metabolism</title>
		<title level="j" type="abbrev">J Cereb Blood Flow Metab</title>
		<idno type="ISSN">0271-678X</idno>
		<idno type="ISSNe">1559-7016</idno>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="929" to="936" />
			<date type="published" when="2001-08" />
			<publisher>SAGE Publications</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Glutamate N-methyl-D-aspartate Receptor Antagonists Rapidly Reverse Behavioral and Synaptic Deficits Caused by Chronic Stress Exposure</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Nanxin</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Rong-Jian</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jason</forename><forename type="middle">M</forename><surname>Dwyer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mounira</forename><surname>Banasr</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Boyoung</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hyeon</forename><surname>Son</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Xiao-Yuan</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">George</forename><surname>Aghajanian</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ronald</forename><forename type="middle">S</forename><surname>Duman</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.biopsych.2010.12.015</idno>
		<idno type="PMID">21292242</idno>
		<idno type="PMCID">PMC3068225</idno>
		<ptr type="open-access" target="http://europepmc.org/articles/pmc3068225?pdf=render" />
	</analytic>
	<monogr>
		<title level="j">Biological Psychiatry</title>
		<title level="j" type="abbrev">Biological Psychiatry</title>
		<idno type="ISSN">0006-3223</idno>
		<imprint>
			<biblScope unit="volume">69</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="754" to="761" />
			<date type="published" when="2011-04" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Stress-Induced Alterations in Prefrontal Cortical Dendritic Morphology Predict Selective Impairments in Perceptual Attentional Set-Shifting</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Liston</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">M</forename><surname>Miller</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">S</forename><surname>Goldwater</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">J</forename><surname>Radley</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">B</forename><surname>Rocher</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">R</forename><surname>Hof</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">H</forename><surname>Morrison</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><forename type="middle">S</forename><surname>Mcewen</surname></persName>
		</author>
		<idno type="DOI">10.1523/jneurosci.1184-06.2006</idno>
		<idno type="PMID">16870732</idno>
		<ptr type="open-access" target="http://www.jneurosci.org/content/26/30/7870.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Journal of Neuroscience</title>
		<title level="j" type="abbrev">Journal of Neuroscience</title>
		<idno type="ISSN">0270-6474</idno>
		<idno type="ISSNe">1529-2401</idno>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="issue">30</biblScope>
			<biblScope unit="page" from="7870" to="7874" />
			<date type="published" when="2006-07-26" />
			<publisher>Society for Neuroscience</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Cellular Mechanisms Underlying the Antidepressant Effects of Ketamine: Role of α-Amino-3-Hydroxy-5-Methylisoxazole-4-Propionic Acid Receptors</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sungho</forename><surname>Maeng</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Carlos</forename><forename type="middle">A</forename><surname>Zarate</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jing</forename><surname>Du</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Robert</forename><forename type="middle">J</forename><surname>Schloesser</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Joseph</forename><surname>Mccammon</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Guang</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Husseini</forename><forename type="middle">K</forename><surname>Manji</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.biopsych.2007.05.028</idno>
		<idno type="PMID">17643398</idno>
	</analytic>
	<monogr>
		<title level="j">Biological Psychiatry</title>
		<title level="j" type="abbrev">Biological Psychiatry</title>
		<idno type="ISSN">0006-3223</idno>
		<imprint>
			<biblScope unit="volume">63</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="349" to="352" />
			<date type="published" when="2008-02" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">LTP impairment by fractalkine/CX3CL1 in mouse hippocampus is mediated through the activity of adenosine receptor type 3 (A3R)</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Laura</forename><surname>Maggi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Flavia</forename><surname>Trettel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Maria</forename><surname>Scianni</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Cristina</forename><surname>Bertollini</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Fabrizio</forename><surname>Eusebi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Bertil</forename><forename type="middle">B</forename><surname>Fredholm</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Cristina</forename><surname>Limatola</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jneuroim.2009.07.016</idno>
		<idno type="PMID">19709758</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of Neuroimmunology</title>
		<title level="j" type="abbrev">Journal of Neuroimmunology</title>
		<idno type="ISSN">0165-5728</idno>
		<imprint>
			<biblScope unit="volume">215</biblScope>
			<biblScope unit="issue">1-2</biblScope>
			<biblScope unit="page" from="36" to="42" />
			<date type="published" when="2009-10-30" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Synaptic Plasticity and AMPA Receptor Trafficking</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Robert</forename><forename type="middle">C</forename><surname>Malenka</surname></persName>
		</author>
		<idno type="DOI">10.1196/annals.1300.001</idno>
		<idno type="PMID">14684431</idno>
		<idno type="ark">ark:/67375/WNG-GXNC89P7-P</idno>
		<idno type="istexId">2344609CAC519390B35B2BD27ED1495ADE446A93</idno>
	</analytic>
	<monogr>
		<title level="j">Annals of the New York Academy of Sciences</title>
		<idno type="ISSN">0077-8923</idno>
		<idno type="ISSNe">1749-6632</idno>
		<imprint>
			<biblScope unit="volume">1003</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="1" to="11" />
			<date type="published" when="2003-11" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">AMPA Receptor Trafficking and Synaptic Plasticity</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Roberto</forename><surname>Malinow</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Robert</forename><forename type="middle">C</forename><surname>Malenka</surname></persName>
		</author>
		<idno type="DOI">10.1146/annurev.neuro.25.112701.142758</idno>
		<idno type="PMID">12052905</idno>
		<ptr type="open-access" target="http://pdfs.semanticscholar.org/0441/e81d3b9b48095e5cd9d08c3eb58f9003388d.pdf" />
	</analytic>
	<monogr>
		<title level="j">Annual Review of Neuroscience</title>
		<title level="j" type="abbrev">Annu. Rev. Neurosci.</title>
		<idno type="ISSN">0147-006X</idno>
		<idno type="ISSNe">1545-4126</idno>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="103" to="126" />
			<date type="published" when="2002-03" />
			<publisher>Annual Reviews</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Concurrent use of cocaine and alcohol is more potent and potentially more toxic than use of either alone—A multiple-dose study</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Elinore</forename><forename type="middle">F</forename><surname>Mccance-Katz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Thomas</forename><forename type="middle">R</forename><surname>Kosten</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Peter</forename><surname>Jatlow</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0006-3223(97)00426-5</idno>
		<idno type="PMID">9715356</idno>
		<idno type="PII">S0006-3223(97)00426-5</idno>
		<idno type="ark">ark:/67375/6H6-XXWH97GD-7</idno>
		<idno type="istexId">EBECAA68BCDC94D09CEA663499EA5BB39527E117</idno>
	</analytic>
	<monogr>
		<title level="j">Biological Psychiatry</title>
		<title level="j" type="abbrev">Biological Psychiatry</title>
		<idno type="ISSN">0006-3223</idno>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="250" to="259" />
			<date type="published" when="1998-08" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">The Action of Antidepressants on the Glutamate System: Regulation of Glutamate Release and Glutamate Receptors</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Laura</forename><surname>Musazzi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Giulia</forename><surname>Treccani</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Alessandra</forename><surname>Mallei</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Maurizio</forename><surname>Popoli</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.biopsych.2012.11.009</idno>
		<idno type="PMID">23273725</idno>
	</analytic>
	<monogr>
		<title level="j">Biological Psychiatry</title>
		<title level="j" type="abbrev">Biological Psychiatry</title>
		<idno type="ISSN">0006-3223</idno>
		<imprint>
			<biblScope unit="volume">73</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="1180" to="1188" />
			<date type="published" when="2013-06" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Anticancer and antimetastatic effects of cordycepin, an active component of Cordyceps sinensis</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kazuki</forename><surname>Nakamura</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kazumasa</forename><surname>Shinozuka</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Noriko</forename><surname>Yoshikawa</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jphs.2014.09.001</idno>
		<idno type="PMID">25704018</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of Pharmacological Sciences</title>
		<title level="j" type="abbrev">Journal of Pharmacological Sciences</title>
		<idno type="ISSN">1347-8613</idno>
		<imprint>
			<biblScope unit="volume">127</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="53" to="56" />
			<date type="published" when="2015-01" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">Examination of Org 26576, an AMPA receptor positive allosteric modulator, in patients diagnosed with major depressive disorder: an exploratory, randomized, double-blind, placebo-controlled trial</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kari</forename><forename type="middle">R</forename><surname>Nations</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Peter</forename><surname>Dogterom</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Roberta</forename><surname>Bursi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jacques</forename><surname>Schipper</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Scott</forename><surname>Greenwald</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">David</forename><surname>Zraket</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Lev</forename><surname>Gertsik</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jack</forename><surname>Johnstone</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Allen</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yogesh</forename><surname>Pande</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ge</forename><surname>Ruigt</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Larry</forename><surname>Ereshefsky</surname></persName>
		</author>
		<idno type="DOI">10.1177/0269881112458728</idno>
		<idno type="PMID">22954616</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of Psychopharmacology</title>
		<title level="j" type="abbrev">J Psychopharmacol</title>
		<idno type="ISSN">0269-8811</idno>
		<idno type="ISSNe">1461-7285</idno>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="1525" to="1539" />
			<date type="published" when="2012-09-06" />
			<publisher>SAGE Publications</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">Involvement of AMPA receptors in the antidepressant-like effects of dextromethorphan in mice</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Linda</forename><surname>Nguyen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Rae</forename><forename type="middle">R</forename><surname>Matsumoto</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.bbr.2015.03.024</idno>
		<idno type="PMID">25804358</idno>
	</analytic>
	<monogr>
		<title level="j">Behavioural Brain Research</title>
		<title level="j" type="abbrev">Behavioural Brain Research</title>
		<idno type="ISSN">0166-4328</idno>
		<imprint>
			<biblScope unit="volume">295</biblScope>
			<biblScope unit="issue">15</biblScope>
			<biblScope unit="page" from="26" to="34" />
			<date type="published" when="2015-12" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">Antidepressant-Like Effect of &lt;i&gt;Cordyceps sinensis&lt;/i&gt; in the Mouse Tail Suspension Test</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Koji</forename><surname>Nishizawa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kosuke</forename><surname>Torii</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Aya</forename><surname>Kawasaki</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Masanori</forename><surname>Katada</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Minoru</forename><surname>Ito</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kenzo</forename><surname>Terashita</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sadakazu</forename><surname>Aiso</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Masaaki</forename><surname>Matsuoka</surname></persName>
		</author>
		<idno type="DOI">10.1248/bpb.30.1758</idno>
		<idno type="PMID">17827735</idno>
		<ptr type="open-access" target="https://www.jstage.jst.go.jp/article/bpb/30/9/30_9_1758/_pdf" />
	</analytic>
	<monogr>
		<title level="j">Biological &amp; Pharmaceutical Bulletin</title>
		<title level="j" type="abbrev">Biol. Pharm. Bull.</title>
		<idno type="ISSN">0918-6158</idno>
		<idno type="ISSNe">1347-5215</idno>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="1758" to="1762" />
			<date type="published" when="2007" />
			<publisher>Pharmaceutical Society of Japan</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">Drug Transport across the Blood–Brain Barrier</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">William</forename><forename type="middle">M</forename><surname>Pardridge</surname></persName>
		</author>
		<idno type="DOI">10.1038/jcbfm.2012.126</idno>
		<idno type="PMID">22929442</idno>
		<idno type="PMCID">PMC3494002</idno>
		<ptr type="open-access" target="https://journals.sagepub.com/doi/pdf/10.1038/jcbfm.2012.126" />
	</analytic>
	<monogr>
		<title level="j">Journal of Cerebral Blood Flow &amp; Metabolism</title>
		<title level="j" type="abbrev">J Cereb Blood Flow Metab</title>
		<idno type="ISSN">0271-678X</idno>
		<idno type="ISSNe">1559-7016</idno>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="1959" to="1972" />
			<date type="published" when="2012-08-29" />
			<publisher>SAGE Publications</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main">Comparison of racemic ketamine andS-ketamine in treatment-resistant major depression: Report of two cases</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Robert</forename><surname>Paul</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Nadine</forename><surname>Schaaff</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Frank</forename><surname>Padberg</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hans-Jürgen</forename><surname>Möller</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Thomas</forename><surname>Frodl</surname></persName>
		</author>
		<idno type="DOI">10.1080/15622970701714370</idno>
		<idno type="PMID">19224412</idno>
	</analytic>
	<monogr>
		<title level="j">The World Journal of Biological Psychiatry</title>
		<title level="j" type="abbrev">The World Journal of Biological Psychiatry</title>
		<idno type="ISSN">1562-2975</idno>
		<idno type="ISSNe">1814-1412</idno>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="241" to="244" />
			<date type="published" when="2009-01" />
			<publisher>Informa UK Limited</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main">A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">Christopher</forename><surname>Pierce</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Peter</forename><forename type="middle">W</forename><surname>Kalivas</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0165-0173(97)00021-0</idno>
		<idno type="PMID">9403138</idno>
		<idno type="PII">S0165-0173(97)00021-0</idno>
		<idno type="ark">ark:/67375/6H6-V0NFNQL7-1</idno>
		<idno type="istexId">FA2A2257570B684C65B005375DE989BE5EE9E22A</idno>
	</analytic>
	<monogr>
		<title level="j">Brain Research Reviews</title>
		<title level="j" type="abbrev">Brain Research Reviews</title>
		<idno type="ISSN">0165-0173</idno>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="192" to="216" />
			<date type="published" when="1997-10" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main">Glutamate-Based Antidepressants: Preclinical Psychopharmacology</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Andrzej</forename><surname>Pilc</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Joanna</forename><forename type="middle">M</forename><surname>Wierońska</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Phil</forename><surname>Skolnick</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.biopsych.2013.01.021</idno>
		<idno type="PMID">23453290</idno>
	</analytic>
	<monogr>
		<title level="j">Biological Psychiatry</title>
		<title level="j" type="abbrev">Biological Psychiatry</title>
		<idno type="ISSN">0006-3223</idno>
		<imprint>
			<biblScope unit="volume">73</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="1125" to="1132" />
			<date type="published" when="2013-06" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title level="a" type="main">Impairments in High-Frequency Transmission, Synaptic Vesicle Docking, and Synaptic Protein Distribution in the Hippocampus of BDNF Knockout Mice</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Lucas</forename><forename type="middle">D</forename><surname>Pozzo-Miller</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Wolfram</forename><surname>Gottschalk</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Li</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kathryn</forename><surname>Mcdermott</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jing</forename><surname>Du</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Raj</forename><surname>Gopalakrishnan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Chikara</forename><surname>Oho</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Zu-Hang</forename><surname>Sheng</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Bai</forename><surname>Lu</surname></persName>
		</author>
		<idno type="DOI">10.1523/jneurosci.19-12-04972.1999</idno>
		<idno type="PMID">10366630</idno>
		<ptr type="open-access" target="http://www.jneurosci.org/content/19/12/4972.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">The Journal of Neuroscience</title>
		<title level="j" type="abbrev">J. Neurosci.</title>
		<idno type="ISSN">0270-6474</idno>
		<idno type="ISSNe">1529-2401</idno>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="4972" to="4983" />
			<date type="published" when="1999-06-15" />
			<publisher>Society for Neuroscience</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title level="a" type="main">Effects of Intravenous Ketamine on Explicit and Implicit Measures of Suicidality in Treatment-Resistant Depression</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Rebecca</forename><forename type="middle">B</forename><surname>Price</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Matthew</forename><forename type="middle">K</forename><surname>Nock</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Dennis</forename><forename type="middle">S</forename><surname>Charney</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sanjay</forename><forename type="middle">J</forename><surname>Mathew</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.biopsych.2009.04.029</idno>
		<idno type="PMID">19545857</idno>
		<idno type="PMCID">PMC2935847</idno>
		<ptr type="open-access" target="http://europepmc.org/articles/pmc2935847?pdf=render" />
	</analytic>
	<monogr>
		<title level="j">Biological Psychiatry</title>
		<title level="j" type="abbrev">Biological Psychiatry</title>
		<idno type="ISSN">0006-3223</idno>
		<imprint>
			<biblScope unit="volume">66</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="522" to="526" />
			<date type="published" when="2009-09" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
		<title level="a" type="main">Repeated stress alters dendritic spine morphology in the rat medial prefrontal cortex</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jason</forename><forename type="middle">J</forename><surname>Radley</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Anne</forename><forename type="middle">B</forename><surname>Rocher</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Alfredo</forename><surname>Rodriguez</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Douglas</forename><forename type="middle">B</forename><surname>Ehlenberger</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mark</forename><surname>Dammann</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Bruce</forename><forename type="middle">S</forename><surname>Mcewen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">John</forename><forename type="middle">H</forename><surname>Morrison</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Susan</forename><forename type="middle">L</forename><surname>Wearne</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Patrick</forename><forename type="middle">R</forename><surname>Hof</surname></persName>
		</author>
		<idno type="DOI">10.1002/cne.21588</idno>
		<idno type="PMID">18157834</idno>
		<idno type="PMCID">PMC2796421</idno>
		<idno type="ark">ark:/67375/WNG-P9NMD4HN-0</idno>
		<idno type="istexId">1DF5048465AC5B9A815B1BAFA301D65BECEFF2C8</idno>
		<ptr type="open-access" target="http://europepmc.org/articles/pmc2796421?pdf=render" />
	</analytic>
	<monogr>
		<title level="j">The Journal of Comparative Neurology</title>
		<title level="j" type="abbrev">J. Comp. Neurol.</title>
		<idno type="ISSN">0021-9967</idno>
		<idno type="ISSNe">1096-9861</idno>
		<imprint>
			<biblScope unit="volume">507</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="1141" to="1150" />
			<date type="published" when="2008-03-01" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b58">
	<analytic>
		<title level="a" type="main">A Randomized, Controlled Trial of IV Versus IM Ketamine for Sedation of Pediatric Patients Receiving Emergency Department Orthopedic Procedures</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mark</forename><forename type="middle">G</forename><surname>Roback</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Joe</forename><forename type="middle">E</forename><surname>Wathen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Todd</forename><surname>Mackenzie</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Lalit</forename><surname>Bajaj</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.annemergmed.2006.06.001</idno>
		<idno type="PMID">17052563</idno>
	</analytic>
	<monogr>
		<title level="j">Annals of Emergency Medicine</title>
		<title level="j" type="abbrev">Annals of Emergency Medicine</title>
		<idno type="ISSN">0196-0644</idno>
		<imprint>
			<biblScope unit="volume">48</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="605" to="612" />
			<date type="published" when="2006-11" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b59">
	<analytic>
		<title level="a" type="main">Characterization of Multiple Phosphorylation Sites on the AMPA Receptor GluR1 Subunit</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Katherine</forename><forename type="middle">W</forename><surname>Roche</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Richard</forename><forename type="middle">J</forename><surname>O'brien</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Andrew</forename><forename type="middle">L</forename><surname>Mammen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jeffrey</forename><surname>Bernhardt</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Richard</forename><forename type="middle">L</forename><surname>Huganir</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0896-6273(00)80144-0</idno>
		<idno type="PMID">8663994</idno>
		<idno type="PII">S0896-6273(00)80144-0</idno>
		<idno type="ark">ark:/67375/6H6-SVZ0MSS1-H</idno>
		<idno type="istexId">6ED0B69FA5781D7652C30821F41DF90672A5B887</idno>
	</analytic>
	<monogr>
		<title level="j">Neuron</title>
		<title level="j" type="abbrev">Neuron</title>
		<idno type="ISSN">0896-6273</idno>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="1179" to="1188" />
			<date type="published" when="1996-06" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b60">
	<analytic>
		<title level="a" type="main">Postsynaptic Receptor Trafficking Underlying a Form of Associative Learning</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Rumpel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Ledoux</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Zador</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Malinow</surname></persName>
		</author>
		<idno type="DOI">10.1126/science.1103944</idno>
		<idno type="PMID">15746389</idno>
		<ptr type="open-access" target="http://pdfs.semanticscholar.org/bb6b/aeb9afaea2a8de8fe04a20c9acc90b6d3bce.pdf" />
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<title level="j" type="abbrev">Science</title>
		<idno type="ISSN">0036-8075</idno>
		<idno type="ISSNe">1095-9203</idno>
		<imprint>
			<biblScope unit="volume">308</biblScope>
			<biblScope unit="issue">5718</biblScope>
			<biblScope unit="page" from="83" to="88" />
			<date type="published" when="2005-04-01" />
			<publisher>American Association for the Advancement of Science (AAAS)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b61">
	<analytic>
		<title level="a" type="main">Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Sanacora</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Treccani</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Popoli</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuropharmacology</title>
		<imprint>
			<biblScope unit="volume">62</biblScope>
			<biblScope unit="page" from="63" to="77" />
			<date type="published" when="2012" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b62">
	<analytic>
		<title level="a" type="main">The selective glucocorticoid receptor antagonist CORT 108297 decreases neuroendocrine stress responses and immobility in the forced swim test</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Matia</forename><forename type="middle">B</forename><surname>Solomon</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Aynara</forename><forename type="middle">C</forename><surname>Wulsin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Taylor</forename><surname>Rice</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Dayna</forename><surname>Wick</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Brent</forename><surname>Myers</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jessica</forename><surname>Mcklveen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jonathan</forename><forename type="middle">N</forename><surname>Flak</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yvonne</forename><surname>Ulrich-Lai</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">James</forename><forename type="middle">P</forename><surname>Herman</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.yhbeh.2014.02.002</idno>
		<idno type="PMID">24530653</idno>
		<idno type="PMCID">PMC4074011</idno>
		<ptr type="open-access" target="http://europepmc.org/articles/pmc4074011?pdf=render" />
	</analytic>
	<monogr>
		<title level="j">Hormones and Behavior</title>
		<title level="j" type="abbrev">Hormones and Behavior</title>
		<idno type="ISSN">0018-506X</idno>
		<imprint>
			<biblScope unit="volume">65</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="363" to="371" />
			<date type="published" when="2014-04" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b63">
	<analytic>
		<title level="a" type="main">Dopamine Receptor Stimulation Modulates AMPA Receptor Synaptic Insertion in Prefrontal Cortex Neurons</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">X</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">E</forename><surname>Wolf</surname></persName>
		</author>
		<idno type="DOI">10.1523/jneurosci.4603-04.2005</idno>
		<idno type="PMID">16093384</idno>
		<ptr type="open-access" target="http://www.jneurosci.org/content/25/32/7342.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Journal of Neuroscience</title>
		<title level="j" type="abbrev">Journal of Neuroscience</title>
		<idno type="ISSN">0270-6474</idno>
		<idno type="ISSNe">1529-2401</idno>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="issue">32</biblScope>
			<biblScope unit="page" from="7342" to="7351" />
			<date type="published" when="2005-08-10" />
			<publisher>Society for Neuroscience</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b64">
	<analytic>
		<title level="a" type="main">Involvement of striatal and extrastriatal DARPP-32 in biochemical and behavioral effects of fluoxetine (Prozac)</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Svenningsson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><forename type="middle">T</forename><surname>Tzavara</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">M</forename><surname>Witkin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">A</forename><surname>Fienberg</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><forename type="middle">G</forename><surname>Nomikos</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Greengard</surname></persName>
		</author>
		<idno type="DOI">10.1073/pnas.052712799</idno>
		<idno type="PMID">11880651</idno>
		<idno type="PMCID">PMC122493</idno>
		<ptr type="open-access" target="http://www.pnas.org/content/99/5/3182.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Proceedings of the National Academy of Sciences</title>
		<title level="j" type="abbrev">Proceedings of the National Academy of Sciences</title>
		<idno type="ISSN">0027-8424</idno>
		<idno type="ISSNe">1091-6490</idno>
		<imprint>
			<biblScope unit="volume">99</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="3182" to="3187" />
			<date type="published" when="2002-03-05" />
			<publisher>Proceedings of the National Academy of Sciences</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b65">
	<analytic>
		<title level="a" type="main">Involvement of AMPA receptor phosphorylation in antidepressant actions with special reference to tianeptine</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Per</forename><surname>Svenningsson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Helen</forename><surname>Bateup</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hongshi</forename><surname>Qi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kogo</forename><surname>Takamiya</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Richard</forename><forename type="middle">L</forename><surname>Huganir</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Michael</forename><surname>Spedding</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Bryan</forename><forename type="middle">L</forename><surname>Roth</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Bruce</forename><forename type="middle">S</forename><surname>Mcewen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Paul</forename><surname>Greengard</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1460-9568.2007.05952.x</idno>
		<idno type="PMID">18088278</idno>
		<idno type="ark">ark:/67375/WNG-VDKP61RW-X</idno>
		<idno type="istexId">5460E1AAA2D6BC7EFF4E74D33800C4B4143A3F5B</idno>
	</analytic>
	<monogr>
		<title level="j">European Journal of Neuroscience</title>
		<idno type="ISSN">0953-816X</idno>
		<idno type="ISSNe">1460-9568</idno>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="3509" to="3517" />
			<date type="published" when="2007-12-10" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b66">
	<analytic>
		<title level="a" type="main">Antidepressant-Like Effects of Cordycepin in a Mice Model of Chronic Unpredictable Mild Stress</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Zhang</forename><surname>Tianzhu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yang</forename><surname>Shihai</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Du</forename><surname>Juan</surname></persName>
		</author>
		<idno type="DOI">10.1155/2014/438506</idno>
		<idno type="PMID">25587342</idno>
		<idno type="PMCID">PMC4284936</idno>
		<ptr type="open-access" target="http://downloads.hindawi.com/journals/ecam/2014/438506.pdf" />
	</analytic>
	<monogr>
		<title level="j">Evidence-Based Complementary and Alternative Medicine</title>
		<title level="j" type="abbrev">Evidence-Based Complementary and Alternative Medicine</title>
		<idno type="ISSN">1741-427X</idno>
		<idno type="ISSNe">1741-4288</idno>
		<imprint>
			<biblScope unit="volume">2014</biblScope>
			<biblScope unit="page" from="1" to="9" />
			<date type="published" when="2014" />
			<publisher>Hindawi Limited</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b67">
	<analytic>
		<title level="a" type="main">Age-dependent effects of chronic stress on brain plasticity and depressive behavior</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Erika</forename><surname>Toth</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Roman</forename><surname>Gersner</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Adi</forename><surname>Wilf-Yarkoni</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hagit</forename><surname>Raizel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Dalit</forename><forename type="middle">E</forename><surname>Dar</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Gal</forename><surname>Richter-Levin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ofir</forename><surname>Levit</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Abraham</forename><surname>Zangen</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1471-4159.2008.05642.x</idno>
		<idno type="PMID">18752645</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of Neurochemistry</title>
		<idno type="ISSN">0022-3042</idno>
		<imprint>
			<biblScope unit="volume">107</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="522" to="532" />
			<date type="published" when="2008-08-22" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b68">
	<analytic>
		<title level="a" type="main">Cordycepin: A bioactive metabolite with therapeutic potential</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hardeep</forename><forename type="middle">S</forename><surname>Tuli</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Anil</forename><forename type="middle">K</forename><surname>Sharma</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sardul</forename><forename type="middle">S</forename><surname>Sandhu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Dharambir</forename><surname>Kashyap</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.lfs.2013.09.030</idno>
		<idno type="PMID">24121015</idno>
	</analytic>
	<monogr>
		<title level="j">Life Sciences</title>
		<title level="j" type="abbrev">Life Sciences</title>
		<idno type="ISSN">0024-3205</idno>
		<imprint>
			<biblScope unit="volume">93</biblScope>
			<biblScope unit="issue">23</biblScope>
			<biblScope unit="page" from="863" to="869" />
			<date type="published" when="2013-11" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b69">
	<analytic>
		<title level="a" type="main">Pharmacological Interaction With the Sigma1 (σ1)-Receptor in the Acute Behavioral Effects of Antidepressants</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Vanessa</forename><surname>Villard</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Johann</forename><surname>Meunier</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Nathalie</forename><surname>Chevallier</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tangui</forename><surname>Maurice</surname></persName>
		</author>
		<idno type="DOI">10.1254/jphs.10191fp</idno>
		<idno type="PMID">21427517</idno>
		<ptr type="open-access" target="https://www.jstage.jst.go.jp/article/jphs/115/3/115_10191FP/_pdf" />
	</analytic>
	<monogr>
		<title level="j">Journal of Pharmacological Sciences</title>
		<title level="j" type="abbrev">J Pharmacol Sci</title>
		<idno type="ISSN">1347-8613</idno>
		<idno type="ISSNe">1347-8648</idno>
		<imprint>
			<biblScope unit="volume">115</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="279" to="292" />
			<date type="published" when="2011" />
			<publisher>Japanese Pharmacological Society</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b70">
	<analytic>
		<title level="a" type="main">Phosphorylation of AMPA Receptors: Mechanisms and Synaptic Plasticity</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">John</forename><forename type="middle">Q</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Anish</forename><surname>Arora</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Lu</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Nikhil</forename><forename type="middle">K</forename><surname>Parelkar</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Guochi</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Xianyu</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Eun</forename><forename type="middle">Sang</forename><surname>Choe</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Limin</forename><surname>Mao</surname></persName>
		</author>
		<idno type="DOI">10.1385/mn:32:3:237</idno>
		<idno type="PMID">16385140</idno>
		<idno type="ark">ark:/67375/VQC-TRRNJ6P9-M</idno>
		<idno type="istexId">ED640F818A5E632E0DE868C69552F75DCF3B6E4F</idno>
	</analytic>
	<monogr>
		<title level="j">Molecular Neurobiology</title>
		<title level="j" type="abbrev">MN</title>
		<idno type="ISSNe">0893-7648</idno>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="237" to="250" />
			<date type="published" when="2005" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b71">
	<analytic>
		<title level="a" type="main">Repeated Stress Causes Cognitive Impairment by Suppressing Glutamate Receptor Expression and Function in Prefrontal Cortex</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Eunice</forename><forename type="middle">Y</forename><surname>Yuen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jing</forename><surname>Wei</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Wenhua</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ping</forename><surname>Zhong</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Xiangning</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Zhen</forename><surname>Yan</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.neuron.2011.12.033</idno>
		<idno type="PMID">22405206</idno>
		<idno type="PMCID">PMC3302010</idno>
		<ptr type="open-access" target="http://www.cell.com/article/S0896627312000839/pdf" />
	</analytic>
	<monogr>
		<title level="j">Neuron</title>
		<title level="j" type="abbrev">Neuron</title>
		<idno type="ISSN">0896-6273</idno>
		<imprint>
			<biblScope unit="volume">73</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="962" to="977" />
			<date type="published" when="2012-03" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b72">
	<analytic>
		<title level="a" type="main">A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Major Depression</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Carlos</forename><forename type="middle">A</forename><surname>Zarate</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jaskaran</forename><forename type="middle">B</forename><surname>Singh</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Paul</forename><forename type="middle">J</forename><surname>Carlson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Nancy</forename><forename type="middle">E</forename><surname>Brutsche</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Rezvan</forename><surname>Ameli</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">David</forename><forename type="middle">A</forename><surname>Luckenbaugh</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Dennis</forename><forename type="middle">S</forename><surname>Charney</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Husseini</forename><forename type="middle">K</forename><surname>Manji</surname></persName>
		</author>
		<idno type="DOI">10.1001/archpsyc.63.8.856</idno>
		<idno type="PMID">16894061</idno>
		<ptr type="open-access" target="https://jamanetwork.com/journals/jamapsychiatry/articlepdf/668195/YOA60007.pdf" />
	</analytic>
	<monogr>
		<title level="j">Archives of General Psychiatry</title>
		<title level="j" type="abbrev">Arch Gen Psychiatry</title>
		<idno type="ISSN">0003-990X</idno>
		<imprint>
			<biblScope unit="volume">63</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page">856</biblScope>
			<date type="published" when="2006-08-01" />
			<publisher>American Medical Association (AMA)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b73">
	<analytic>
		<title level="a" type="main">Replication of Ketamine&apos;s Antidepressant Efficacy in Bipolar Depression: A Randomized Controlled Add-On Trial</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Carlos</forename><forename type="middle">A</forename><surname>Zarate</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Nancy</forename><forename type="middle">E</forename><surname>Brutsche</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Lobna</forename><surname>Ibrahim</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jose</forename><surname>Franco-Chaves</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Nancy</forename><surname>Diazgranados</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Anibal</forename><surname>Cravchik</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jessica</forename><surname>Selter</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Craig</forename><forename type="middle">A</forename><surname>Marquardt</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Victoria</forename><surname>Liberty</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">David</forename><forename type="middle">A</forename><surname>Luckenbaugh</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.biopsych.2011.12.010</idno>
		<idno type="PMID">22297150</idno>
		<idno type="PMCID">PMC3343177</idno>
		<ptr type="open-access" target="http://europepmc.org/articles/pmc3343177?pdf=render" />
	</analytic>
	<monogr>
		<title level="j">Biological Psychiatry</title>
		<title level="j" type="abbrev">Biological Psychiatry</title>
		<idno type="ISSN">0006-3223</idno>
		<imprint>
			<biblScope unit="volume">71</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="939" to="946" />
			<date type="published" when="2012-06" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
